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Summary 
 
Backgrounds: Chronic obstructive pulmonary disease (COPD) is one of the most common 
chronic diseases in the world, and it is expected to become the third leading cause of death 
worldwide in 2030.  
 
Exacerbation is a major event in the natural history of COPD, and repeated exacerbations 
result in reduced quality of life, accelerated lung function decline and increased risk for death, 
particularly in those requiring hospitalization. The length of hospital stay (LOS) is usually 
long (6-10 days) and readmission rate is high (up to 60% in the following year).  
 
A wide range of factors have been associated with prolonged LOS with little consistency 
between the studies. Many of the factors reported are related to disease severity and/or aging 
and therefore are not amenable for intervention. Both hospital organizations and resources and 
clinical pathways have been shown to reduce LOS. Few published studies based their analysis 
on variables gained from emergency rooms, and to our knowledge, no predicting model has 
been established for LOS based on these variables.    
 
Readmission rate is a challenge to the traditional health care system. Most of the interventions 
reducing readmission rate have been carried out after discharge and applied new elements in 
healthcare services, e.g. patient education emphasising self-management and long term 
follow-up by multidisciplinary team. There is limited information about whether treatment of 
acute exacerbation in a specialised pulmonary department contributes to lower readmission 
rates than treatment in other internal medicine departments. 
 
Hospital at Home (HaH) with assistant early discharge, a new health care service, has been 
shown to shorten the hospital stay and reduce the readmission rate compared to traditional 
hospital treatment for selected patients with acute exacerbation of COPD. Moreover, patients 
receiving home treatment were more satisfied and would prefer home treatment in the future. 
However, there is a lack of detailed information about what these HaH patients were satisfied 
with and why they preferred this form of health care. 
 
In Norway, as in other industrialized countries, COPD exacerbation is one of the most 
common causes of hospital admission in the internal medicine department. In spite of this 
fact, the data about the exacerbation-related outcomes of hospitalized patients are still sparse. 
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Further, HaH has not been tried out and thus lack of literature of the patients’ experiences 
with HaH. Therefore the aims of this thesis are:  
 
1. To identify the predictors of long LOS when hospitalized for acute exacerbation of 
COPD and to establish a predicting model for LOS based on variables available in 
emergency room on admission  
2. To determine whether COPD patients treated in specialized Pulmonary Department 
had lower readmission rates than comparable patients treated in other medicine 
departments at the same hospital 
3. To explore patients’ experiences with a HaH programme with assistant early discharge 
program after hospitalization for acute exacerbation of COPD 
 
Methods: The medical records of 599 patients hospitalized for acute exacerbation of COPD 
at Oslo University Hospital, Aker between March 2006 and December 2008 were collected 
retrospectively in order to answer the first and second research questions. We registered the 
following data: LOS of the first hospitalization in the defined period (index admission), 
number of COPD-related readmissions in the following 12 months after the index admission 
(readmission rate), and patients’ demographic and medical data that were readily available in 
the emergency room on admission. We used multivariate logistic regression analysis to assess 
the association between variables on admission and long LOS and a receiver-operator 
characteristic (ROC) analysis was performed to assess the performance of the predicting 
model. A propensity-matched pair analysis was used to select comparable patients discharged 
from the Pulmonary Department and the other medicine departments. Paired t-test was used to 
compare the readmission rates of the matched patients discharged from the Pulmonary 
Department and other medicine departments.  
 
To answer the third research question, we used data collected from semi-structured interviews 
of nine patients who participated in a randomised controlled trial (RCT) assessing the long 
term effect of a HaH programme for patients hospitalized for acute exacerbation of COPD. 
Six participants were randomised to receive HaH care and three to receive traditional hospital 
care. The interviews were audio-taped, transcribed and analysed by a four-step method for 
systematic text condensing.  
 
Results: Results are presented in three papers. The main findings are:  
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Admission on Thursday-Saturday, co-morbidities, high partial arterial tension of CO2 and low 
serum albumin level were associated with a long LOS. The predicting model was less 
successful and had area under the curve 0.7, which means a less satisfactory predictability. 
 
We found a non-significant trend of lower readmission rate in favour of patients discharged 
from the Pulmonary Department after an acute exacerbation episode of COPD one year 
following the index admission. 
 
Patients receiving home care experienced the HaH programme as safe. They expressed that 
information they gained from this programme was adapted to specific situations in their daily 
lives and given in a familiar environment which had a positive impact on their self-
management of COPD. 
 
Discussion: Reasons for a prolonged LOS and high readmission rate are probably multi-
factorial and may indicate the need for better chronic care, as highlighted by findings in our 
qualitative study: patient involvement and a need for adapted information and follow-up. This 
is important for developing new and effective health services for patients with chronic 
disease.  
 
Knowledge about predictors of prolonged LOS may help physicians identify patients at risk of 
a long LOS in the early stages of an AECOPD admission and therefore may assist discharge 
planning. Although the readmission rate for patients treated and discharged from a pulmonary 
department is not significantly lower than comparable patients discharged from other 
medicine departments, there may be other benefits of being treated in a specialized pulmonary 
department, as documented in other studies. 
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1 Introduction 
 
1.1 Chronic obstructive pulmonary disease 
Until the late 1950s, there was profound international confusion about the use of terms such 
as emphysema, chronic bronchitis and asthma. One of the first attempts to propose a term to 
cooperate all these three existing terms was at the Ciba Guest Symposium in 1958. In the 
symposium report published in 1959, “chronic non-specific lung disease” was proposed to 
include all three conditions and “generalized obstructive lunge disease” including “reversible” 
and “irreversible obstructive lung disease referred to asthma and emphysema.”1 Shortly after 
the Ciba symposium, the term “chronic obstructive pulmonary disease (COPD)” was 
introduced in North America, referring to patients without atopy and with minimal 
reversibility of the air flow limitation. In 1984, Fletcher and Pride revised the terminology 
COPD and in 1987 the American Thoracic Society (ATS) made a consensus statement of 
COPD which included asthma in the definition by using a Venn diagram.2,3 
 
In 2001, the Global Initiative for Chronic Obstructive Lung Disease (GOLD), as a project of 
the World Health Organization (WHO) and the U.S. National Heart, Lung, and Blood 
Institute, released a consensus report and defined COPD as “a disease state characterised by 
airflow limitation that is not fully reversible” which is associated with “an abnormal 
inflammatory response of the lung to noxious particles or gases.”4 This was the first time that 
“inflammation” was incorporated into the definition of COPD. The report was revised in 2006 
and 2011 in addition to the annual update. In the last version, co-morbidity and exacerbation 
were taken into the definition for the first time and the assessment of COPD was no longer 
based solely on the spirometry documented airflow limitation but on the combination of 
patient’s symptom level, existing co-morbidities and future risk of exacerbation. This 
illustrated the increasing knowledge of the nature of COPD as a systemic disease with multi-
organ affection and the importance of patient aspects of this disabling disease.5 
 
1.1.1 Definition, diagnostic criteria and risk factors 
According to GOLD, COPD is a common preventable and treatable disease characterized by 
persistent airflow limitation that is usually progressive and associated with an enhanced 
chronic inflammatory response in the airway and the lung to noxious particles or gases. 
Exacerbations and co-morbidities contribute to the overall severity in individual patients.5 
 14
 
The combination of symptoms, exposure to risk factors and persistent airflow limitation are 
required to diagnose COPD. The cardinal symptoms are dyspnea, chronic cough or sputum 
production. The most common risk factors are tobacco smoke, smoke from home cooking and 
heating fuels, occupational dusts and chemicals or family history of COPD. Spirometry has to 
be performed and post-bronchodilator fixed ratio of forced expiratory volume in 1 s (FEV1)/ 
forced vital capacity (FVC) < 0.70 is required to confirm the diagnosis of COPD. 
 
1.1.2 Pathology and pathophysiology 
The chronic inflammary process elicited by sigarette smoking or other noxious particles 
involves all anatomical regions of the lung, i.e. airways, lung parenchyma and vasculature.6 
Although the exact mechanisms for the inflammatory process are still unknown, oxidative 
stress, protease-antiprotease imbalance and genetic factors play a role.7 The inflammatory 
process is facilitated by different types of mediators (chemotaxines, cytokines and growth 
factors) released by inflammatory cells such as neutrophiles, macrophages.8 Persistent 
inflammation, even after smoking cessation, causes continuous tissue damage in the entire 
tracheobronchial tree and lung parenchym with subsequent repair and results in a permanent 
structual and functional change.9 
 
It is clear now that chronic inflammation exists not only in the patient’s lung but the whole 
system although how and why is still unknown. One theory is that systemic inflammation is a 
result of a “spill over” of inflammation in the lungs to the systemic circulation.10-13 Other 
theories have also been described.4,14,15. 
 
The complexity of the pathogenesis of COPD is reflected in the broad variation of clinical 
phenotypes. The term “chronic systemic inflammatory syndrome,” suggested to be added to 
the diagnosis of COPD, reflects the complexity of the problem.16 Thus one management 
regime could not possibly fit all patients, and individual assessment is necessary.  
 
1.1.3 Co-morbidities  
We know that co-morbidities are common at any severity level of COPD and they have a 
significant impact on a patient’s prognosis. 17-20 In fact, many patients with COPD die of non-
respiratory diseases such as cardiovascular disease (~25%), cancer (mainly lung cancer, 20-
33%) and other causes (30%).21-24 Respiratory failure accounts for up to 40% of deaths 
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primarily in patients with severe COPD, depending on the population studied and criteria 
used.25  
 
The most frequent co-morbidities in COPD are cardiovascular diseases, including ischemic 
heart disease, heart failure, atrial fibrillation and hypertension. Other common co-morbidities 
are osteoporosis, metabolic syndrome, diabetes, lung cancer, anaemia, malnutrition, atrophy 
and dysfunction of skeletal muscles, pulmonary vascular disease, physical intolerance, anxiety 
and depression (figure 1).  
 
 
Fig. 1. Systemic effects and co-morbidities of chronic obstructive pulmonary disease (COPD). Barnes and Celli.  
Reproduced from Eur Respir J 2009; 33: 1165-1185. Peripheral lung inflammation may cause a “spill-over” of cytokines, such as interleukin 
(IL)-6, IL-1β and tumour necrosis factor (TNF)-α, into the systemic circulation, which may increase acute-phase proteins such as C-reactive 
protein (CRP). Systemic inflammation may lead to skeletal muscle atrophy and cachexia and may initiate and worsen co-morbid conditions. 
Systemic inflammation also may accelerate lung cancer. An alternative view is that systemic inflammation causes several inflammatory 
diseases including COPD.  
 
In contrast to other co-morbidities, anxiety and depression, with a higher prevalence in more 
severe COPD, often remain undiagnosed and untreated.26,27 Depression increases the risk of 
exacerbation, frequent admission and poor survival.28-30 The exact mechanism of depression is 
unknown, but it has been supposed to be multi-factorial.31 Risk factors such as age, smoking, 
hypoxemia and decline of health status, as well as systemic inflammation with IL-6, may play 
a role in the pathogenesis of the development of depression in COPD.32 
 
In 2011, the GOLD Initiative for first time introduced a multi-dimentional tool to assess 
COPD’s severity and the future risk of exacerbation. Although the degree of airway 
obstruction, FEV1, is still important in assessing COPD, it has been realized that FEV1 is only 
weakly correlated with patients’ symptoms and health-related quality of life.5,33,34 Rodriguez-
Roisin and Agusti have called this a change of paradigm in their comments in the latest 
version of GOLD’s strategy report.35 Other aspects of COPD that are gaining more attention  
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during the past decade include dyspnea, exacerbations, co-morbidities including 
psychological disorder, regular physical activity, exertional desaturation, peripheral muscles,  
body composition, nutritional status, hormone balance, effort intolerance, and quality of life.36 
This illustrates the beginning of a new era: a more individualized assessment and treatment of 
this complex disease.  
 
1.1.4 The natural history of COPD 
This heterogeneous and complex disease has probably more than one natural history.37 The 
disease is usually progressive and has no cure, and may lead to death. The time frame of 
progression is generally long and has wide individual variations.While cough and sputum are 
the predominant symtoms in some patients, dyspnea may be the only symptom in others. 
Some individuals show a rapid decline in lung function, while others show a slow, roughly 
stable decline. Stopping exposure to noxious agents related to COPD may slow the disease 
pregression, and regular treatments may control symptoms and improve quality of life. As a 
consequence of this complexity, the discrepancy of reported mortality is large among COPD 
patients. While the TORCH study, based on outpatients with COPD, reported a three-year 
mortality of 14.3%, the mortality rate dramatically increased in patients who had been 
hospitalized for COPD exacerbations.38 Three- and five-year mortality after hospitalization 
increases to 55 and 75% respectively.39,40 Thus, knowledge about how to prevent 
hospitalization and reduce readmission is important for improve prognosis for this patient 
group.  
 
1.1.5 Socioeconomic burden 
COPD is one of the most common chronic diseases in the world, and the World Bank/World 
Health Organization projects it will be the third leading cause of death and fifth leading cause 
of morbidity by 2020.41 The prevalence among adults in Europe, Australia and North America 
ranges from 4% to 10%.42 Based on a Hordaland County cohort study, the prevalence of 
GOLD-defined COPD in Norway is 7% and the prevalence of earlier GOLD-defined severe 
and very severe disease is 1%.43 The average annual incidence of COPD in the general 
population aged 18-74 years is approximately 0.7%.44 
 
The social burden is less obvious and more complicated to estimate. The disability-adjusted 
life year (DALY) estimates the overall burden of a disease, expressed as the number of years 
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lost due to ill-health, disability or early death.45 The COPD was the 11th leading cause of lost 
DALYs in the world in 2002 and it was expected to climb to 7th place in 2030.46 
 
The economic and social burden of COPD is substantial and still increasing.47 According to 
the European Lung White Book published by European Respiratory Society (ERS) in 2003, 
the estimated annual direct costs of COPD in the European Union are € 38.6 billion.48 The 
corresponding estimation in the U.S. was $29.5 billion and the indirect costs are $20.4 
billion.49 In Norway, the estimated direct medical costs for people aged ≥40 yrs in 2005 was 
approximately € 141 million.50 The cost of hospital admission is the most important direct 
cost in the economic evaluation of COPD.51 Hospitalization represents more than 40% of the 
overall costs of COPD care, and for the most severe patients, it can be more than 60%.52,53  
 
1.2 Exacerbation 
1.2.1 Definitions and classifications  
Both symptom- and event-based definitions of exacerbation have been described in the 
literature. The symptom-based definition was described by Anthonisen et al. and required 
worsening or increased dyspnoea, with or without sputum and sputum purulence.54 The 
ISOLDE Study suggested the treatment-based definition at the beginning of the 21st century; 
it said exacerbation should lead to changes in treatment.33 GOLD defined exacerbation as an 
acute event characterized by a worsening of the patients’ symptoms that is beyond day-to-day 
variation and leads to a change in medication.35,55,56 
 
Exacerbation has been increasingly recognized as an important event in the natural history of 
COPD. The growing evidence in the past decade showed that exacerbations negatively affect 
the patients’ quality of life, worsen the symptom and lung function, which may take weeks to 
recover, accelerate lung function decline and increase mortality, particularly in those requiring 
hospitalization.39,57 Furthermore, the socioeconomic costs are high.58,59 
 
No single biological marker has been proved to be capable of assessing the severity of 
exacerbation yet. The American Thoracic Society (ATS) and European Respiratory Society 
(ERS) proposed the most common classification based on the treatment required for the 
current exacerbation. The three degrees of severity are as follows: mild, an increase in 
respiratory symptoms controlled by the patient with an increase in the usual medication; 
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moderate, requiring treatment with systemic glucocorticosteroids and/or antibiotics; and 
severe, requiring hospitalization or a visit to the emergency department.60 
 
1.2.2 Length of hospital stay in hospitalization for exacerbation 
Hospitalization is common for patients with severe exacerbation. The average length of stay 
(LOS) for patients hospitalized for acute exacerbation of COPD is long and the variation of 
reported LOS is large—it ranges from 3 to 16 days, probably due to the population 
studied.61,62 There is no established standard LOS for COPD exacerbation. Prolonged LOS 
increases the risk of adverse events and may reinforce the negative effect of hospitalization. 
Both long and short LOS had been associated with an increased risk for readmission. 
Saynajakangas found that LOS of shorter or longer than 7 days was associated with an 
increased risk of readmission.63 Sin et al. observed that although patients with hospital stay of 
less than 4 days were younger and had less co-morbidity, they were 39% more likely to be 
readmitted and 45% more likely to die within 15 days of discharge than those who stayed 4 to 
6 days. Furthermore, the risk was highest among patients whose stay was less than or equal to 
1 hospital day.64 While premature discharge may result in a “swing door” phenomenon as 
proposed by Capewell, the prolonged LOS may indicate more fragile patients and therefore an 
increased risk of readmission.65,66 
 
Different variables are associated with long LOS in acute exacerbation of COPD, such as 
social/demographic data, clinical variables, co-morbidities, number and type of drugs used 
and day of the week for admission.30,62,63,67-74 However, there is little consistency in the 
predictors of long LOS between different studies.  
 
Since patients with long LOS may be more fragile and need more help after hospitalization, 
they need to be identified to optimize discharge planning. Few studies have assessed LOS 
based on variables obtained in the emergency room. To the best of my knowledge, there are 
no statistical models to predict LOS based on variables collected at the time of hospital 
admission for acute exacerbation of COPD. Increased knowledge about predictors of length of 
stay (LOS) may contribute to better discharge planning and shortening the LOS. 
 
1.2.3 Readmission 
Patients who have had a hospitalization for acute exacerbation of COPD have an increased 
risk of readmission because earlier hospital admission for exacerbation is the most consistent 
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single predictor of rehospitalisation.75 This factor is a non-modifiable risk factor that may be a 
surrogate marker of disease severity. Also dyspnoea, oral corticosteroids, using LTOT, low 
health status, and not having routine physical activity were all associated with an increased  
risk of readmission.75-78 Moreover, readmission rates are high, and up to 63% of patients are 
readmitted within one year after hospitalization for acute exacerbation of COPD.75,78 
Consequently, the reduction of rehospitalisation may improve the patient’s prognosis and  
reduce the socioeconomic burden of the disease.  
 
The high readmission rates illustrated the challenge the health care system faces with COPD 
as a progressive chronic disease. As mentioned earlier, the most of interventions that reduce 
readmission rates are performed after hospital discharge and include self-management 
education, multidisciplinary team involvement and long term follow-up.79-82 
 
To my knowledge, there has not been published intervention studies aimed at reducing of 
readmission before hospital discharge. Several observational studies about the impact of 
hospital organization on readmission have been published. The UK National COPD Audit 
2003 found no association between an increased use of respiratory consultants or better 
organized inpatient care and readmissions.83 While one US study showed no differences in 
readmission rate between patients treated by hospitalists, general internists or family 
physicians, a Finnish study showed that the readmission risk of patients with COPD treated 
by general practitioners was nearly twice that of patients treated by specialists.84,85 The high 
COPD readmission rate remains a challenge to health care services.  
 
1.2.4 Patient perception of acute exacerbation  
The wide negative impact of acute exacerbation has been clearly documented.22, 44,45,48-51 The 
negative effects of hospitalization itself such as immobility and risk of falls in older people, 
accentuation of the existing social isolation, and depression, are well known.86-89 Depression 
and anxiety persist in a high percentage of patients even after the discharge, which in turn 
increases the risk of readmission.77,90 
 
However, the literature about patients’ experiences of acute exacerbation is limited, although 
there are some qualitative studies about patients’ experiences living with advanced COPD.91,92 
One quantitative survey studied the impact of exacerbation on a patient’s daily life without 
providing detailed description of patients’ experiences of exacerbation.93 One observational 
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study of 125 patients from five countries, which used a qualitative design, but presented its 
findings in quantitative way with diagrams and numbers, showed that anxiety evoked the 
patients’ most concern because they were worried about dying, suffocating, worsening of 
their condition and hospitalization.94 The same study also documented the considerable 
impact of acute exacerbation on the patient’s family that causes fear and worry.  
 
By interviewing patients and their family caregivers within 24 hours of hospitalization for 
acute exacerbation, Bailey wrote an article called “Death Stories”.95 This was the first 
qualitative study carried out while patients were acutely ill and still receiving intravenous 
steroids and antibiotics. According to the author, eight of the ten family units told death 
stories. “These death stories usually portrayed two kinds of acute dyspnoeic episodes. They 
described either a distinct moment in time when the participant thought they or the person 
they had been caring for had died (and been resuscitated)—a near-death story—or an incident 
when the storyteller feared dying or witnessing a death event—a shadow-of-death story”. This 
illustrated how dramatic acute exacerbation may be for the patients and their families.  
 
1.2.5 Relieve the burden of exacerbation: the role of new care models 
Both quantitative and qualitative studies have shown the obvious negative impact of 
exacerbation on patients, their families and society, as mentioned earlier. Therefore, good 
disease control aimed at preventing exacerbation or prompt treatment of exacerbation when 
exacerbation is already there is of great importance. Several new forms of health care have 
shown potential in better disease control. 
 
1.2.5.1 Hospital at Home with assistant early discharge  
Hospital at home (HaH) has become a common health service in some countries as a response 
to increased demand for acute hospital beds.96 Although the variety of schemes within the 
concept of HaH is considerable, there is a common feature—patients treated by HaH would 
be admitted to hospital if HaH care was not available. The HaH admission avoidance regime 
recruits patients directly from the community by general practitioners or the emergency 
department. HaH with assistant early discharge recruits patients from those already 
hospitalized. In this study, I will concentrate on HaH with assistant early discharge. 
 
Evidence from several randomised and controlled trials (RCT) from different countries 
showed that selected patients hospitalized for acute exacerbation of COPD can be treated at 
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home safely with the support of a respiratory nurse.97-103 Usually, after up to 3 days of 
hospital stay, patients who satisfied the criteria were discharged after randomized to home 
treatment and followed up by a respiratory nurse with home visits over a period of up to 2  
weeks or longer. The nurse could consult to a pulmonologist if necessary. If conditions 
worsen, the patients could be readmitted to hospital directly. A Cochrane review concluded 
that patients receiving HaH care had a significantly lower readmission rate and a non-
significant trend to lower mortality than patients who received conventional hospital care.104  
 
In spite of the promising results of the HaH programme, it is important to be aware of the 
danger of burden shift when moving acute hospital care to home, e.g., family members being 
inflicted with an extra burden.105 Some studies have explored the issue. A survey study from 
the US concluded that family members of HaH patients at lower rates experienced potentially 
stressful situations, and that when such situations occurred, they were less often associated 
with self-reported stress.106 The results agree with another study of self-reported stress of 
caregivers to HaH patients in other diseases.107 
 
1.2.5.2 Integrated care 
Integrated care, which combines hospital and home treatment for patients with complicated 
diseases, is one way to reduce the pressure on hospital beds.108-110 The American Thoracic 
Society workshop report defined integrated care as “a continuum of patient-centered service 
organized as a care delivery value chain for patients with chronic conditions with the goal of 
achieving the optimal daily functioning and health status for the individual patient and to 
achieve and maintain the individual’s independence and functioning in the community.”111 
The chronic care model proposed by Wagner provides a template for integrated care that 
encompasses six key components: self-management support, clinical information system, 
delivery system redesign, decision support (guidelines), healthcare organization, and 
community resources. 112,113 The literature on other chronic diseases has shown that integrated 
care may contribute to improved function capacity, higher quality of life, and enhanced 
possibility to live at home with less help.114-116 
 
In COPD, this form of care is still in the early developing stage. Bourbeau et al. showed that 
intervention promoting a self-management programme supported by a skilled case manager 
and continuous telephone follow-up reduced hospitalization and improved patients’ health 
status.117 Casas et al. showed that shared care arrangements after hospitalization among 
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different levels of the health system can reduce subsequent hospitalization.118 Koff et al. 
reported on the significant improvement of health-related quality of life, earlier detection of 
COPD exacerbations, and a trend toward a reduction in health care utilization of proactive 
integrated care for patients with very severe COPD.119 Rice et al. reported on the reduction of 
emergency department visits and hospitalizations in patients with severe COPD.120 
 
As the socioeconomic burden of chronic disease increases, the resources in the health care 
system need to be utilized more efficiently. Hospitals have disease-specific competence but a 
limited capacity to handle the large population of chronically ill patients. In the primary care, 
physician has closer contact with patients and a better overview of patients and their home 
situations and therefore can offer more holistic care. The combination of primary and hospital 
care may offer chronically ill patients more comprehensive care.  
 
1.2.5.3 Multidisciplinary care 
COPD patients suffer from a large range of co-morbidities and, together with their family, 
need to cope with a wide range of problems such as symptoms, disabilities, emotional 
distress, complex medication regimens, difficult lifestyle adjustments and obtaining help for 
medical care for the rest of their life.113 Therefore, care including collaboration between 
different professionals is important. Pulmonary rehabilitation is an example of 
multidisciplinary care. There is strong evidence of its positive effects on dyspnoea, exercise 
performance, health-related quality of life, physical and emotional functional status and 
reduced health care use in stable COPD patients.121 Recently, it also has been shown that early 
pulmonary rehabilitation immediately after hospital admission for acute exacerbation of 
COPD is a highly effective and safe intervention to reduce hospital admissions and mortality 
and to improve health-related quality of life.82 
 
The challenge to pulmonary rehabilitation is that its benefits decrease gradually over time. 
Without follow up after pulmonary rehabilitation, the patients run the risk of unhealthy 
transitions, of returning to a vicious cycle of inactivity, physical deconditioning and social 
isolation during the shifting and progressive course of their illness.122,123 This is confirmed by 
a Norwegian qualitative study that showed that the patients experienced the period after 
rehabilitation as challenging and expressed the need for extended support from both 
professionals and peers in this critical period when new practices were going to be 
implemented and motivation of self-management maintained.124 Thus, incorporating 
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principles of pulmonary rehabilitation into the existing health care system and home settings 
may be the subject for future practice. 
 
1.2.5.4 Self-management: the central element in the new care models 
Self-management is the cornerstone of integrated care, chronic care model and 
multidisciplinary care. The term applies to any formalized patient education programme 
aimed at teaching the skills necessary to carry out medical regimens specific to the disease,  
guide health behaviour change, and provide emotional support for patients to control their  
disease and live functional lives.117 This is accomplished by (1) formulating treatment goals 
relevant to the patient, (2) encouraging patients to experiment with adaptive behaviours in 
everyday situations, (3) encouraging problem-solving and decision-making, and (4) 
promoting self efficacy.111 
 
The most important component of a self-management approach in COPD is probably the 
instruction in the prevention and early treatment of COPD exacerbation through an action 
plan. Although the details might differ, the recognition of deterioration in symptoms and the 
initiation of predetermined steps, including starting medications such as oral steroids and 
antibiotics and promptly communicating with a healthcare provider, are essential contents in 
these action plans.125 The early recognition of exacerbation symptoms followed by early 
treatment reduces the duration of exacerbation and/or hospital admission rate.126 
 
A meta-analysis of self-management education in COPD consisting of eight trials concluded 
that this intervention was associated with a reduction in hospital admission and improved 
health status.80 Because of the diversity of programmes, the review could not make specific 
recommendations on content or format of the intervention. With help of self-management 
strategies, patients may get a more active role in control of this chronic and progressive 
disease. However, self-management by itself is not enough—the needs for expert support in 
decision-making and behaviour changes in the long term is necessary.79 
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1.2.6 Patient experience of new care models 
All these care systems mentioned above were developed to improve disease control and 
improve the chronically ill person’s quality of life. However, studies about the detailed 
description of patient’s experience with these care models are sparse. A survey showed more 
satisfaction in patients in the HaH programme than patients receiving traditional hospital care, 
and patients and carers would prefer HaH in the case of new COPD exacerbation requiring 
hospital admission.100 However, it did not describe what the patients were satisfied with and 
why patients preferred HaH. The design of the study might explain this. Surveys, quantitative 
studies, are suited to comparing differences but they are not able to give in depth descriptions 
of how and what. On the other hand, qualitative studies can explore phenomena like this in 
more details and find out what make patients prefer HaH over traditional hospital care.  
 
Clark et al. explored the experiences of a HaH programme and concluded that not all patients 
found the home nursing component of the service helpful, and that the patients felt they were 
not being actively involved in the early discharge process.127 In a quantitative study, Schofield 
et al. showed that the patients and their families preferred home treatment delivered by a 
nurse-led acute respiratory assessment service; they followed up with a qualitative study to 
understand what made patients prefer home treatment. In their qualitative study, the patients 
expressed that the reasons for their satisfaction and preference were the accessibility and ease 
of use of the service, specialist clinical skills of the health professionals, and one-to-one care 
in the home (familiar environment) by the friendly and approachable nurses. Monninkhof et 
al. showed that patients who participated in a comprehensive self-management programme—
including self-management education and a fitness programme in an outpatient clinic—felt 
safe.128 The patients attributed this feeling to frequent follow-up and 24-hour accessibility of 
the hospital and a low barrier to seeking help. However, a detailed description of the patients’ 
experiences of the home treatment programme is lacking and more research is needed.129 
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2 Aims 
 
COPD is a progressive and complex disease with multi-organ affection. Although only a 
minor proportion of patients will be hospitalized for COPD, the total socioeconomic burden 
of hospitalization and the distress for patients and their caregivers are considerable. The 
negative consequences of exacerbations are clearly documented and the prognosis of patients 
with severe exacerbation requiring hospitalization is poor; the hospital stay is long, the 
readmission rate is high and both short- and long-term mortality is high. A wide range of 
clinical and demographic parameters are associated with long hospital stay with little 
consistency between studies. Few studies have assessed the effect of what department patients 
are admitted to on readmission rate. To release the increased pressure on hospital beds, 
Hospital at Home (HaH) with supported early discharge for selected patients admitted for 
acute exacerbation of COPD has had promising effects on length of hospital stay and the 
readmission rate. However data on patients’ experiences of HaH are sparse. 
 
In Norway, as in other industrialized countries, acute exacerbation of COPD is one of the 
most common causes of hospital admission in the internal medicine department. In spite of 
this fact, the outcome data of hospitalized patients are still limited. Therefore this study will:  
 
1. Identify the factors associated with long length of stay when hospitalized for acute 
exacerbation of COPD and try to establish a predicting model for long length of stay 
based on variables available at emergency room on admission  
2. Determine whether COPD patients treated in a specialized pulmonary department had 
lower readmission rates than comparable patients treated in other internal medicine 
departments at the same hospital 
3. Explore patients’ experiences of a HaH with supported early discharge program after 
hospitalization for acute exacerbation of COPD 
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3 Materials and methods 
 
3.1 The quantitative studies (paper I and II) 
Different data are needed to answer the research questions. Quantitative data from a review of 
medical records were used to answer the first and second research question, and qualitative 
data from in-depth interviews were used to answer the third research question. 
 
3.1.1 Study population 
The study population in the quantitative studies consists of patients admitted to Oslo 
University Hospital, Aker, for exacerbation of COPD from March 2006 to December 2008. 
Patients belonging to one of the following three diagnosis categories were considered as 
patients with COPD-related admissions and included in this study: 1) primary discharge 
diagnosis was COPD (J43-44), according to ICD-10 (International Classification of Diseases, 
10th revision);130 2) pneumonia (J12-J18) as primary diagnosis with COPD (J43-J44) as a 
secondary diagnosis; 3) respiratory failure (J96) as primary diagnosis with COPD (J43-J44) as 
a secondary diagnosis. Patients with COPD-related admission but incomplete medical records 
during the 12 months after discharge were excluded. For patients with multiple admissions in 
the inclusion period, the relevant data from the first admission, or index admission, were 
extracted.  
 
After searching the hospital register for ICD - 10 inclusion criteria, 599 patients were 
identified. Of these, 33 patients died in the hospital and 566 were discharged alive. In paper I 
we studied the whole population, and in paper II we studied only those discharged alive.  
 
3.1.2 Data collection 
The computerized medical records of all included patients were manually reviewed. 
Demographic, clinical and administrative data on the index admission were extracted. 
Demographic data included age, sex, and whether living alone or living in nursing home or 
other institutions. Clinical data included co-morbidities, smoking status, medications, long-
term oxygen therapy (LTOT), blood pressure (mmhg), pulse (heart beats per minute), results 
of blood test including arterial blood gas, description of chest x-ray and others. The 
administrative data included length of stay (LOS) in days, day of week of admission, 
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discharge department (pulmonary medicine, endocrinology, gastroenterology, geriatrics, 
haematology, infectious diseases or an observation unit connected to the emergency unit), 
number of admissions due to acute exacerbation of COPD during 12 months before and 12 
months after the index admission, or to the date of death, if applicable.  
 
Spirometry 
The following spirometrical value closest in time to the index admission was extracted: forced 
vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and FEV1/FVC. Body weight 
and height were recorded, and body mass index (BMI), defined as weight in kilograms 
divided by the square of height in meters, was calculated. FVC and FEV1 values are expressed 
in litres and as a percent of predicted using the Gulsvik standard.131 
 
Laboratory results and chest radiograph  
In addition, the results of all laboratory analyses sampled in the emergency room on 
admission were retrieved from the hospital’s laboratory database. The following results were 
registered: haemoglobin concentrations (g/dl), white blood cell count (x109/l), serum C-
reactive protein (mg/l), serum creatinin (umol/l), serum glucose (mmol/l), serum total protein 
level (g/l) and serum albumin level (g/l). The values of arterial blood gases sampled in the 
emergency room were also registered. All the descriptions of chest radiographs were 
manually reviewed and categorized as whether or not there were infiltrates consistent with 
pneumonia. 
 
Co-morbidities 
The following major co-morbidities were registered: ischemic heart disease, cardiac 
arrhythmias, congestive heart failure, cor pulmonale or pulmonary hypertension, psychiatric 
disorder; general atherosclerosis, cerebral insult, diabetes mellitus, neurologic disorders other 
than cerebral insult, any malignancy ever, osteoporosis, kidney failure, or abuse of drugs or 
alcohol. 
 
3.1.3 Organization of different departments 
The staff of the Pulmonary Department at Aker Hospital consists of pulmonologists, 
residents, nurses and a physiotherapist. The residents rotated between the different 
departments within the internal medicine department every 6 months as part of a 
specialization program in internal medicine. Other staff in the Pulmonary Department worked 
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on a more permanent basis. The residents, under the supervision of pulmonologists, carried 
out the rounds and decided on treatments, discharge planning and follow-up.  
 
The other medicine departments were organized in a similar way, except that the senior 
physicians had internal medicine sub-specialities other than pulmonary medicine. Patients in 
need of non-invasive ventilation (NIV) were centralized to an intensive care unit, and the 
criteria for use of NIV was defined in line with international guideline.5 
 
3.1.4 Self-management program  
In the Pulmonary Department unit, the staff had designed a self-management program aimed 
at reducing COPD-related readmissions. This program included five steps as follows: (1) 
Group education regarding different aspects of COPD directed to the patients and their family 
caregivers; (2) Individual review of a self-management program for the early treatment of 
new episodes of AECOPD; (3) Strengthening the contact with the patients’ general 
practitioners at discharge; (4) Mediation of assistance from the primary healthcare provider 
when needed; (5) Assessment of the need for and possible referral to pulmonary 
rehabilitation.  
 
This self-management program was offered only to the patients in the Pulmonary Department 
on an informal basis, the participation in the program was not systematically registered.  
 
The quantitative study was accepted by the local Privacy Ombudsman for Clinical Research at 
Oslo University Hospital (2011/12102). The Regional Committee for Medical Research 
Ethics in South-East Norway advised that approval for the study from them was not necessary 
(S-09079d, 2009/123). 
 
3.1.5 Data analyses 
Since detailed descriptions of methods have been presented in the respective papers, we only 
describe the respective statistic methods briefly here.  
 
In the quantitative study, missing values for FEV1, BMI, serum albumin and the partial carbon 
dioxide tension in arterial blood (PaCO2) were imputed from the other known variables using 
multiple linear regression analysis. Patients with missing values after this procedure were 
excluded from the final analysis.  
 29
 
We defined long length of stay (LOS) as LOS>75th percentile (11 days). Both univariate and 
multivariate logistic regression analyses had been done. The multivariable analysis initially 
included variables with p≤0.25 in the univariate analysis. Variables were then manually 
removed one by one while watching changes in the coefficients in order to arrive at a final 
parsimonious model. In order to evaluate the performance of the predicting model Receiver 
operating characteristic (ROC) analysis was performed and area under the ROC curve was 
calculated.  
 
In order to select comparable patients discharged from Pulmonary Department and other 
medicine departments, the propensity score to each patient was calculated and used to match 
patient on the 1:1 basis. A propensity score is the statistical chance a patient has of having an 
exposure given the observed variables.132 The propensity score in this study was the 
probability for a patient being discharged from the Pulmonary Department, as predicted using 
a logistic regression model. The matching was based on the predicted log odds ratio of the 
propensity score. After matching process, we got two comparable patients who were actually 
discharged from Pulmonary Department and other medicine departments. Then COPD-related 
readmissions within 12 months after discharge between these two patient groups were 
compared using paired t-test. The readmission rate was further adjusted for those who died 
before the end of the 12-month follow-up period. 
 
In all the analyses, the level of statistical significance was set at p<0.05. Stata software 
(version 10.1) was used for all statistical analyses and psmatch2 procedure for pairwise 
matching in paper II (Stata Corp, College Station, TX, USA). 
 
3.2 The qualitative study (paper III) 
Material in the qualitative study consists of semi-structured interviews of nine patients who 
had been recruited through a randomized and controlled trial (RCT) investigating long-term 
effects of a HaH programme (ISRCTN 36101176). 
3.2.1 Hospital at home programme 
After years of planning, the RCT started to include patients in autumn in 2008. Main inclusion 
criteria were that the patients were considered to have acute exacerbation of COPD and 
needed hospital admission. The main exclusion criteria were life threatening respiratory 
 30
failure, confusion or not being able to give written consent, impaired consciousness and 
changes in chest x-ray or co-morbidities in need of further inpatient investigation or 
treatment. Patients were allocated to HaH or continued hospital treatment within 36 hours  
after the primary evaluation of patients at the emergency room. The RCT experienced a slow 
inclusion rate and was terminated after a year because of this. At this point 12 patients were 
included.  
 
Patients randomized to home treatment (HaH patients) were visited by a specialised hospital 
nurse once a day in a period of three days. The visit lasted up to one hour depending on the 
needs. The nurse evaluated the patients’ clinical status and essential clinical parameters, 
obtained blood samples for later analysis when needed, and assessed whether or not the 
patients could still be treated at home. The nurse could consult a pulmonologist in case of 
worsening of the patients’ symptoms. After the consultation, decisions were made on 
frequency of follow-up, therapy changes or readmission to the hospital. Furthermore, the 
nurse invited the patient and his/her spouse to a dialogue, e.g. she asked how the patient felt 
and encouraged them to reflect on possible causes of the acute exacerbation and how to 
prevent it. During the three-day period the patients could call the hospital at any time if they 
were concerned about their condition, especially regarding indications for readmission. 
Inpatients were treated according to ordinary hospital routines. Both patient groups were 
during the subsequent year offered three outpatient follow-up consultations with a 
pulmonologist in the hospital. The first visit was approximately six weeks after discharge. 
 
3.2.2 Study sample 
All 12 patients recruited to the RCT were considered eligible. After excluding three patients 
because their medical condition had worsened, all of whom had received in-hospital 
treatment, nine patients were included. Six patients received HaH treatment (HaH patients) 
and three received traditional hospital treatment (inpatients). The patients varied in age from 
50-80 years old, sex, civil status, (previous) occupations, co-morbidities, and COPD history 
including earlier COPD-related hospital admissions. The inpatients were interviewed in order 
to see the HaH patients’ experiences in light of traditional hospital care.  
 
Written informed consent was obtained from all participants, and the study was approved by 
the Regional Committee for Medical Research Ethics, South-East Norway (08-158-07292b 
1.2007.2613). 
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3.2.3 Data collection 
The empirical data in paper III consists of transcriptions of semi-structured audio-taped in-
depth interview of nine patients based on Kvale’s principles.133 This means that the researcher 
had prepared interview guides for the two informant groups (HaH patients and inpatients) 
before the interview (appendix), but the guides were used flexibly. This implied that all the 
questions in the guide were asked, but different topics could be explored more deeply in 
different interviews and new topics could be brought up by the informants during the 
interviews. The researcher could follow up this with further questions in order to get more 
information about the new topics. The interview guides in this qualitative study included 
questions about the patients’ experiences and their benefit of the treatment programme.  
 
The interviews were carried out in the patients’ home between seven and ten weeks after 
hospital discharge, except for one interview that was conducted in the outpatient clinic. The 
interviews lasted between 60 and 90 minutes with the HaH patients, and 30 minutes with the 
inpatients. Four spouses (three of the HaH patients and one of the inpatients) were present and 
participated in varying degree in the interviews.  
 
3.2.4 Data analysis: systematic text condensing  
The analysis was carried out in collaboration with the supervisors and according to a 
systematic text condensing method. This method is elaborated on Giogi’s psychological 
phenomenological analysis principles and includes the following four steps alternating 
between the various steps throughout the entire process as described by Malterud: (1) Reading 
through the whole material to obtain an overall impression; (2) Identifying themes 
representing different aspects of the patients’ experiences and coding these under different 
thematic headings (i.e. coding groups). The coding groups “feeling safe,” “individually 
adapted information,” and “managing strategies” were developed; (3) Abstracting and 
condensing the content within each coding group; and (4) Summarising the content within 
each thematic heading. Suitable quotations were chosen to illustrate the findings.134,135  
 
The analysis focused on the patients’ experiences of the HaH programme, and whether the 
patients had obtained something from the programme that helped them to manage their  
chronic illness in everyday life. This was seen in light of the inpatients’ experiences of  
traditional hospital care. 
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4 Summary of results 
 
Paper I: Factors associated with a long hospital stay in patients with acute exacerbation 
of COPD 
In this paper, we started with 599 patients who had been admitted for acute exacerbation of 
COPD. Nine were excluded from the further analysis because of missing data after data 
imputation of albumin, PaCO2 and FEV1. The average age of the final population with 590 
patients was 73.2 ±10.8 years (mean±SD). Of them 54% were women. Mean length of stay 
(LOS) was 8.9±9.7 days, with a median of 6.0 days (interquartile range 3.5–11.0). Mean 
serum albumin level (g/l) was 38.8r4.6; mean PaCO2 (kPa) was 5.9r1.6; mean FEV1(l/s) was 
1.0 r0.50. There were 42 (7%) patients who had long-term oxygen therapy and 498 (84%) 
patients had at least one co-mobidity. Number of patients admitted on Thursday-Saturday was 
237. 
 
In univariate analysis, FEV1, COPD-related admission during the previous 12 months before 
the current admission, admission during Thursday–Saturday, having at least one co-morbidity, 
high PaCO2 and low serum albumin level were significantly associated with a LOS longer 
than 11 days (p<0.05, Table 2).  In multivariate analysis, only admission during Thursday–
Saturday, having co-morbidity, high PaCO2 and low serum albumin level were independently 
associated with a long LOS (Table 3). Admission during Thursday–Saturday increased the 
odds ratio (OR) of a LOS longer than 11 days to 2.24 [95% confidence interval (CI) 1.60–
3.51]. The OR for the presence of co-morbidity compared with no co-morbidity was 2.08 
(95% CI 1.08–4.02). An increase of 1 kPa in PaCO2 had an OR of 1.26 (95% CI 1.13–1.41), 
and an increasing serum albumin level was associated with a shorter LOS (OR 0.92 [95% CI 
0.87–0.97]). The area under the ROC curve was 0.70, which means a less satisfactory 
predictability. 
 
Paper II: Readmissions for COPD: propensity case-matched comparison between 
pulmonary and non-pulmonary departments 
In this paper, we started with a population of 566 patients who were discharged alive after the 
index admission for acute exacerbation of COPD. Of them, 85 were excluded because of 
missing data after the data imputation of FEV1 and BMI. Of those 481 available for analysis, 
247 were discharged from the Pulmonary Department and 234 from other medicine 
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departments. The matching process resulted in 155 matched pairs which did not differ 
significantly from each other concerning covariates, and these patients were used for analysis 
of COPD-related readmissions.  
 
The readmission rate was 0.8 (SD 1.3) per year per patient discharged from the Pulmonary 
Department and 1.1 (1.9) for those discharged from other medicine departments (p=0.09). 
There was a tendency for the readmission rate to be lower among those discharged from the 
Pulmonary Department. Since some of the patients died during the 12 months follow-up 
period, and therefore contributed to false low readmission rate, we made adjusting for 
exposure time by annualization at individual level. After this procedure, the respective 
readmission rate per patients per year was 1.1 (2.3) and 1.6 (4.0) (p=0.17) for patients 
discharged from Pulmonary Department and other medicine departments.  
 
In the negative binomial regression analysis, the incidence rate ratio for readmission during 
the subsequent 12 months for patients discharged from the Pulmonary Department versus 
patients discharged from the other medicine departments adjusted for exposure time was 0.71 
(95% confidence interval 0.47–1.06; p=0.09). 
 
Paper III: Patients with acute exacerbation of chronic obstructive pulmonary disease 
feel safe when treated at home: a qualitative study 
Semi-structured interviews were carried out with six patients who received hospital at home 
(HaH) treatment programme and three patients received traditional hospital care. The 
interviews lasted between 60 and 90 minutes with the HaH patients, and 30 minutes with the 
inpatients. Four spouses (three of the HaH patients and one of the inpatients) were present and 
participated in varying degree.  
 
The most important finding was that patients who received HaH treatment programme and 
their family caregivers felt safe during the treatment period of 3 days despite the limited help 
they got from the hospital. Several elements have been pointed out by the patients as 
contributing factors of their feeling of safe. Firstly, the adapted and individualized 
information made them feel in “safe hands”. The knowledge of COPD and its impact, how to 
handle symptoms in daily life as well as correct use of drugs, different types of inhalation 
devices and medical equipments was high valued. Different patients struggled with different 
problems in their daily life, and the information, according to the patients, was directed to 
 34
their personal concerns and thus easier to remember. Secondly, the framework of the Hospital 
at Home programme made patients feel safe. The possibility of telephone consultation with 
the pulmonary department and instant readmission when needed was important. The 
competence and stability of the health personnel and the predictability of the home visit 
helped reassure patients. The time frame of the home visit—up to one hour daily—gave 
patients an opportunity to ask questions and discuss solutions for big and/or small challenges 
in their everyday lives. The familiar home environment created a unique opportunity to 
remind patients about how they used to struggle in their daily lives. Another finding related to 
the individual information was the positive impact on the patients’ self-management of COPD 
by applying the new knowledge they gained from the HaH programme.  
 
The safety issue for patients receiving traditionally hospital care is a certainty. However, they 
did not receive information other than the relevant results of investigations done in the 
hospital.  
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5 General discussion 
 
5.1 Methodological considerations 
5.1.1 Overall study design 
Both quantitative and qualitative methods were chosen for this study, based on our research 
questions. In general, the quantitative method using statistical or mathematical techniques is 
suitable to compare differences, predict outcomes, and discover correlations or frequencies 
and test a hypothesis. The empirical material consists of numbers. In this study, we chose a 
retrospective design for the quantitative study because it is less time consuming and cheaper 
than a prospective study. The main drawback was missing data which we cannot control.  
 
In the quantitative studies, parameters and outcomes such as age, sex, co-morbidities, 
readmission rate, and length of stay (LOS) are clearly defined. The hypothesis was established 
before the data was collected, i.e. patients discharged from the Pulmonary Department had 
lower readmission rate than the comparable patients discharged from other medicine 
departments. Our goal was to test this hypothesis and association between collected variables 
and long LOS. Therefore a quantitative method was suitable.136  
 
Qualitative research methods were developed within the social and human sciences; they refer 
to theories on interpretation (hermeneutics) and human experiences (phenomenology).136 The 
notion “qualitative” refers to the quality, characteristic, hallmarks or nature of phenomenon 
under study. The qualitative research method is suitable to investigate the meaning of social 
phenomena as experienced by the people themselves.137 Qualitative methods are also useful to 
the study of thoughts, expectations, meaning, attitudes and processes, especially related to 
interaction, relations, and interpretation–all core components of clinical knowledge.136 The 
third research question in this study was to explore the patients’ experiences of a Hospital at 
Home programme; therefore a qualitative method was suitable. 
 
A qualitative design uses various strategies for systematic collection, organisation, and 
interpretation of textual material obtained by talking with people or through observation. The 
ultimate goal is understanding the phenomenon studied and identifying new questions rather 
than definite answers.135 These methods are increasingly recognized in medicine and public 
health research.138 The empirical material consists of texts and results aims to describe the 
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phenomena studied or generate a new conception or theory. In the research process, the 
researcher plays an active role in the development of knowledge. In our qualitative study, we 
chose to talk with patients by interviewing them to obtain data.  
 
In summary, the character of the research question decided the choice of research method.  
 
5.1.2 The quantitative studies (paper I and II) 
5.1.2.1   Sample selection and data collection 
This is a retrospective study, and the selection of patients was based on the discharge 
diagnoses. This made us depend on the practice of the clinicians. We decided to accept the 
diagnoses made as they were and not change them, although we could see that the diagnoses 
of a small minority of patients with available spirometry value were not correct according to 
the GOLD definition.5 However, we excluded the patients with inconsistent diagnoses over 
time; for example, the same patient got asthma (J45) and COPD in different hospital 
admissions. The percentage of missing spirometry values was comparable with another study, 
indicating that the quality of data does not differ largely in similar populations.139 Although 
some patients might be labelled with COPD without spirometry confirmation, we included 
these patients, too, since these patients were treated as if they had COPD.   
 
Every medical record of index admission and the readmissions of included patients were 
manually reviewed and searched for variables we planed to collect. Though the process was 
time consuming, we got more accurate and detailed data than data based on administrative 
data only. We had no control of the blood samples ordered, parameters measured or missing 
data. Compared to a prospective design in which all variables are systematically collected for 
every patient, this is an obvious drawback. In order to reduce the uncertainty of missing data, 
we imputed what we considered important variables such as FEV1, albumin and PCO2, as 
described in the method. This imputation also contributed to avoid excluding patients with 
missing of these data, which would have reduced the statistical power of the studies. Patients 
with missing data after the data imputation were excluded.  
 
There were few missing values for laboratory tests. This might be because at Aker hospital, 
there was a general “basic package” of blood samples taken in the emergency room for all 
patients that referred for assessment of hospital admission in the Internal Medicine Division; 
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therefore there was little difference between patients concerning the blood samples analyzed. 
We considered the overall data quality of this real world study was good.  
 
The study population was recruited from a single university hospital in Oslo, and it might not 
represent other regions. However, the population included was relatively large and was 
unselected because all patients with a discharge diagnosis of COPD were included. 
Furthermore, both the age and LOS in our study were comparable to those in other, larger 
studies, which support the representativeness of our sample.83,140  
 
However, the population was smaller after the matching process in paper II. A post hoc power 
calculation showed that a sample size of 310 patients enabled us to detect differences in 
readmission rates of 0.32 SD, with 80% power and α=5%. This could be classified as a small-
to-medium effect size on the scale of Cohen's d, where 0.2 is defined as a small, 0.5 a medium 
and 0.8 as a large effect size.141 We might have increased the sample size by relaxing the 
criteria for matching. However, this would have reduced the comparability of the patient 
groups and led to a more biased result. Despite the limited power, our result is consistent with 
those of larger observational studies using different study designs and methods.83,84 
 
5.1.2.2   Management in different departments 
The method section described the organization and daily activity in the different departments. 
The major challenge in paper II was that we did not have detailed information about the 
possible differences in treatment and patient management between the two patient groups. 
The self-management programme was offered only to patients discharged from the Pulmonary 
Department. Originally, we aimed to analyse the effect of the self-management program, 
since the programme, although brief, included patient education and a self-management plan 
that, together with other interventions might reduce the readmission rate.117,118 Consequently, 
some of the patients discharged from the Pulmonary Department might have been more able 
to manage a new COPD exacerbation and possibly prevent readmissions, e.g. the programme 
would rather inflate than deflate the difference in readmission rates between the Pulmonary 
Department and the other medicine departments. However, the identity and number of 
patients who participated in the self-management program were not systematically registered 
despite the standardized template for discharge report. We realized that the assessment of the 
programme’s effect on readmission was impossible and instead, we decided to assess the 
overall effect of discharge from Pulmonary Department versus other medicine departments. 
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As reported by a study from UK, more respiratory consultants and related staff reduces the 
length of stay and in-hospital mortality of the exacerbated COPD patients.83 Therefore we 
wanted to assess whether better accessibility to pulmonologists would result in a reduced 
readmission rate.  
 
We are not aware of other variables we could use to describe the difference in medical 
practices between the Pulmonary Department and the other medicine departments. We have 
included the available variables in the propensity score. However, there might be important 
unobserved variables that we cannot take into account. 
 
5.1.2.3   Data analyses 
Annulization of readmission rate at individual level 
We decided to annualize the COPD related readmission rate for each patient because a 
considerable number of patients died during the subsequent 12 months of the follow up 
period; therefore some patients might have fewer readmissions than if the patients were alive. 
After annualization, the differences in the readmission rate was mathematically increased 
from 0.3 to 0.5 between the departments, but at the same time the p-value also increased from 
0.09 to 0.17, or the statistical differences in the readmission rate were decreased. Because of 
differences in time “at risk” if patients died within the first year, we think it is reasonable to 
adjust for the actual observation time by annualization.  
 
Propensity score method 
The propensity score method employs a balancing score that aims to correct bias in patient 
selection by creating equivalent risk groups for analysis. The propensity score method is well 
accepted and widely used in observational studies in medicine.142,143 Compared to 
conventional modelling approaches, this method reduces the bias of estimates by balancing 
the background characteristics and thus more reliable selection of comparable populations in 
observational studies.144 The propensity score in paper II was the probability of a patient 
being discharged from the Pulmonary Department, as predicted using a logistic regression 
model. The selection of variables for the model was based on the assumption that all available 
factors that could influence the clinician deciding where to allocate patients should be 
included. Since over-fitting of propensity score models are not a problem, we allowed the 
final model to include many covariates.145 An unadjusted comparison of patients discharged  
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from the Pulmonary Department and other internal medicine departments showed a 
significant difference in length of stay, number of patients using inhaled corticosteroids and 
long-acting β2-agonist and the proportion of patients receiving non-invasive ventilation. After 
applying the propensity score model, however, the differences were no longer statistically 
significant. We believed that this procedure enabled us to select comparable patients 
discharged from Pulmonary Department and other medicine departments and ensured the 
comparison of readmission rate between these two patients groups was fair. Although there 
are obvious advantages with this model, we have to remember that the propensity score model 
does not adjust for unknown confounders. Furthermore, the inclusion of unobserved or 
unmeasured covariates in the model may, instead of correcting overt bias, introduce bias.146 
Therefore, the proper application of the propensity score method is essential to benefit from 
the advantages of the method. 
 
5.1.3 The qualitative study (paper III) 
As Malterud points out, whether qualitative methods are scientific research methods depends 
on systematic collection, organization and interpretation of textual material obtained from talk 
or observation.136 She also proposed that relevance, validity, and reflexivity are overall 
standards for qualitative studies.  
 
5.1.3.1   Study sample 
The study sample consisted of six home patients and three inpatients varied in age, sex, 
marital status, earlier professions, earlier history of hospitalization for COPD and earlier 
participation in a pulmonary rehabilitation programme. Three spouses participated in the 
interviews and complemented information about what happened during the home treatment 
period. During the interviews, two female spouses gave a more detailed description of 
emotional reactions during the home treatment period and told that they also helped male 
informants remember practicing the advice from the visiting nurse after the home treatment 
period. Although six informants are not a lot, it is not unusual in  qualitative studies to have a 
few informants.147 
 
5.1.3.2   Data collection 
In this qualitative study, semi-structured in-depth interviews were carried out to collect the 
empirical data. The interviews were audio-taped and transcribed word by word right after the  
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interview by my self. I also wrote down my immediate impression of the interview and the 
observation obtained from the informants’ home. This was done in order to better understand 
the context for the informants’ experiences. Although the transcription process was time 
consuming, it gave me a good opportunity to evaluate my interview technique and role during 
the interview and a chance to improve my interview techniques. Since Norwegian is not my 
native language, I was particularly aware if there were any expressions or nuances of the 
language I did not know. In order to avoid misunderstanding, I repeated the sentences or came 
up with a confirming sentence such as, “You mean …”, when I was not sure about what had 
been said, or I just asked the informants whether I had understood correctly. This strategy is 
also in accordance with accommodation within literature about qualitative methods.133  
 
The flexibility of the interview allowed both informants and their family carers to come up 
with new topics and give detailed description about their experiences and feelings. The open-
ended questions enabled informants to describe their experiences in their own way without 
feeling that this might not be “correct.” Some informants were richer in words than others, 
and different informants emphasized different topics depending on what made the most 
impression during the home treatment period.  
 
The patient inclusion was done by the clinicians at the Pulmonary Department and the home 
visits carried out by the specialized nurse. I recruited the informants at the 6-week follow-up 
myself. The informants knew I am a physician and working with this project. I emphasized 
that I interviewed them as a researcher and would like to hear about the negative experiences 
of the home treatment programme. Of course, my profession as a physician who is trained to 
conclude and make diagnosis as the conversation continues, could mean I took a more leading 
role than desired during the interview. My supervisor reminded me of the importance of 
asking open-ended questions, especially about the negative experiences of the treatment 
programme. It seemed that the patients felt free to talk and I got information about both 
positive and negative experiences of the programme during the interviews and we got a good 
variety of experiences. 
 
The home environment also may have enriched the interviews in the way that informants 
remember more details from the home treatment period. They even used the furniture to 
demonstrate how and what the nurse told them to do. Also, it appeared natural for the family 
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caregivers to participate in the interviews and supply with valuable information. One 
interview was carried out at the outpatient clinic and it was shorter than others. The patient 
had gone through several examinations and was anxious about getting home, thus some 
information might have been missed.  
 
All the informants were interviewed about 6 weeks after they received home treatment 
programme. Some of the informants had difficulties remembering details of what happened 
during the 3 days home treatment period. Earlier interview might reduce this problem. 
 
5.1.3.3   Analysis method 
The interview transcriptions were analysed according to a method of systematic text 
condensation.135 The analysis was done in cooperation with my supervisors. After several 
code processes, the coding groups “feeling safe,” “individually adapted information,” and 
“managing strategies” were developed. With this method, we summarized the contents across 
the informants and therefore lost the opportunity to get more detailed information from each 
single informant. Although their life stories could help us better understand the background 
for their perception of the treatment programme, we were more interested in the informants’ 
experiences with the programme.   
 
5.1.3.4   Validity 
With internal validity, we ask what it is true about.134 An accepted theoretical principle when 
using qualitative methods is that many different version of reality exist, and they can be valid 
simultaneously.136 We will never know exactly what happened; only what patients perceived 
during the 3 days’ home treatment period. In other words, we only see events through the eyes 
of the patients. 
 
The data in this qualitative study was systematically collected by semi-structured interviews 
and then transcribed and analyzed by a text condensation method. The results were a 
description of the informants’ experiences with the Hospital at Home treatment programme, 
e.g. what the study was intended to investigate, and thus the internal validity was good. 
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According to Malterud, the nature and extent of the data will ascertain which conclusions can 
be drawn about external validity.134 External validity asks in what contexts the findings can be 
applied.  
 
The most important finding of the qualitative study is that the patients treated at home felt 
safe during the home treatment period of three days. The adapted individualized information, 
the availability of help by telephone and possibilities to be readmitted at any time in the 
treatment period contributed to the patients’ safety. Giving the nature of exacerbation 
symptoms such as increased breathlessness, which could be life-threatening, in combination 
with the frequent co-morbid condition of anxiety, we were surprised that the safety issue is 
not mentioned more in the literature.  
 
Monnikohf described in their study the feeling of safety as “an interesting finding which 
appeared to be very important for the patients.”128 The patients in their study, which were not 
hospitalized for COPD, participated in a much more comprehensive trial that included a self-
management education course and fitness programme that lasted more than 2 years, related 
their feeling of safety to several components, including frequent follow-up, 24 hour-access to 
the hospital and low barriers to seeking help. Our patients with acute exacerbation and treated 
at home with limited help in only three days also pointed out the same feeling, illustrating that 
the importance of safety for COPD patients is a more general concern.  
 
The fact that information contributes to the patients’ feeling of safety is not unique in a COPD 
context. Qualitative studies about patients with severe congestive heart failure (CHF), a 
similar patient group with high mortality and similar symptoms like breathlessness, anxiety 
and limited function level, also reported similar findings.148,149 Harding et al. reported that 
“being uninformed about CHF contributed to the patients’ anxiety.”150 Selman et al. reported 
that “the silence around end-of-life issues was a source of fear and anxiety for both patients 
and carers.”151 This corresponds with our finding that information may contribute to the 
feeling of safety.  
 
5.1.3.5   Reflexivity 
Reflexivity is another important aspect of qualitative methods. Malterud describes reflexivity 
as “an attitude of attending systematically to the context of knowledge construction, 
especially to the effect of the researcher, at every step of the research process.”134 Therefore, 
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researchers should make it clear for both themselves and readers how their own 
preconceptions may affect the results of a study. 
 
For me, growing up in a different culture with a different approach to interpersonal 
relationships and the doctor-patient relationship, the qualitative study brought me into a 
different world. I learned to see things from a different angle and it helped me understand how 
patients and their family caregivers experienced the treatment programme. The home 
environment made deep impression on me. To see with my own eyes the informants’ 
struggles with their daily lives, the worries of the family caregivers, and the psychological 
distress COPD brought, made me reflect about my own practice as physician. It was great to 
see that despite of their personal problems, the informants were positive about the treatment 
programme and grateful for the help they got. I believe the qualitative research process will 
help me to communicate better with the patients, take patients’ view into consideration and 
mediate my clinical message in a more realistic and understanding way. I hope this can in turn 
contribute to improved adherences of the patients. 
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5.2 Discussion of results 
 
5.2.1 Length of hospital stay 
This study assessed two clinical outcomes of COPD exacerbation, length of stay (LOS) and 
COPD-related readmission rate. We found that partial pressure of carbon dioxide in the 
arterial blood, serum albumin level, co-morbidity and admission on Thursday-Saturday were 
associated with LOS. Patients admitted for COPD exacerbation and discharged from the 
Pulmonary Department did not have a lower readmission rate than comparable patients 
discharged from other internal medicine departments during 12 months of follow-up after 
discharge. We also explored patients’ experiences of a Hospital at Home treatment program 
(HaH) of the acute exacerbation of COPD. We found that patients receiving home treatment 
(home patients) for COPD exacerbation felt safe and appreciated the individualized 
information that helped them manage COPD in their daily lives.  
 
Currently there is not established standard for LOS in COPD exacerbation. This might be due 
to the heterogeneity of patients admitted and the complexity of the disease. Over the past two 
decades, the trend of LOS has decreased internationally.59,63,152 Despite this reduction, the 
most commonly reported mean or median LOS is still 6-10 days, and thus, more than the 
“necessary” 6 days as indicated by Mushlin et al. in 1991.67,70,83,140 Neither pharmacological 
improvement over the past decades, application of non-invasive ventilation treatment, nor the 
development of new forms of health services such as HaH and other forms of integrated care 
reduced LOS so much that it is shorter than the “necessary” LOS suggested more than 20 
years ago.  
 
There might be several explanations for the relatively long LOS in COPD, and both patient- 
and non-patient factors are involved. Considerably more efforts have been made to identify 
patient-related factors than non-patient related factors. Among patient-related factors, both 
demographic and clinical variables have been reported; for example, age, sex, living alone, 
requirement of social work during hospital admission, and residence in socioeconomic 
deprived area.63,67,69,73,74 Among clinical variables, lung function, blood pressure, arterial 
blood gas value, acute lower respiratory infection, co-morbidities, number and type of drugs 
used on admission, severity of dyspnoea and performance status have been 
reported.62,67,69,70,73,83,153 Most of these factors reflect the overall health condition of the  
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patients and the severity of COPD and are therefore not amenable for interventions, especially 
interventions during a short period of hospital stay. Thus it makes sense that only 8% of inter-
hospital and 12% of inter-patient variations of LOS could be explained by the patient-related 
factors.73,154 In contrast to the extensive research on patient-related factors, much fewer non-
patient-related factors have been explored. Price et al. found that the organization and 
resources of health care services may influence LOS in the way that an increased number of 
respiratory consultants was associated with shorter LOS.83 Also the application of a clinical 
pathway may reduce LOS.155 
 
Our results in the median LOS (6 days) and LOS-related patient factors (co-morbidities, 
PaCO2 and serum albumin level) are in line with published studies.67,70,83 However, 
admission day of week, which is a non-patient related factor, is seldom commented upon in 
the COPD literature. A Spanish study documented the association between prolonged LOS 
and weekend admission for COPD (Friday-Sunday) where long LOS was defined as more 
than 3 days.69 Another study from Singapore studied the impact of admission on the weekend 
and public holidays not only for COPD but also other diseases, and found prolonged LOS for 
patients hospitalized in these days.156 The authors of the respective articles suggested that the 
reason for prolonged LOS might be due to the reduction and discontinuity of the medical 
staff, which is an organizational question. Since only a minor percent of differences in LOS 
between hospitals could be explained by patient-related factors, non-patient related factors 
such as organizational factors may play a more important role than we are aware of. 73 Price et 
al. commented their results that increased number of respiratory consultant were related to 
lower mortality and shorter LOS as the effect of “something about the whole unit with a 
higher number of respiratory consultant staff” and “not necessarily the individual care offered 
by each single consultant” without further comments what this “something” could be. 
 
One of the results of our qualitative study indicated that this “something” might be 
competence among health professionals and/or the way patients were treated, which made 
patients feel “safe” and “in good hands.” The process creating this safe feeling may in turn be 
reflected in reduced mortality and shorter LOS. Mushlin et al. commented in their article that 
one reason why the actual LOS was longer than medically necessary was that the physicians 
wanted to observe patients another day to be sure the patients could manage themselves at 
home after discharge.70 If the physicians knew the patients would be taken care of after 
discharge, they might not keep these patients in the hospital an extra day, as was case in our  
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qualitative study where patients were discharged after 1.5 days of hospital stay and were 
followed up by a respiratory nurse in the following 3 days after hospital discharge. Their 
hospital stay was very short compared to the common average LOS. However, the home 
patients in our qualitative study explicitly expressed that they felt safe because of the 
competence of the visiting nurse and the trust established between them. They also mentioned 
that knowing they could call the nurse/hospital at any time during the follow-up time made 
them feel “taken care of.” Therefore the easy availability of good quality health services may 
contribute to their feeling of safety and influence LOS, as indicated by Agdoabo et al., who 
found it more likely to discharge patients within a shorter distance to the hospital than 
otherwise.67 This might be because health care is more available in areas near the hospital and 
the threshold of discharge could be lower. It is understandable that safety is the patients’ 
major concern—how can we ensure it should be the major concern of the health care system, 
too.  
 
There are indications that adequate LOS may contribute to patients’ safety and, for some 
patients, it is medically necessary to be hospitalized longer than others. Saynajakangas et al., 
after assessing more than 72,000 COPD hospitalizations, concluded that LOS of 7 days gave 
the longest interval to the subsequent hospitalization for COPD.63 They also found that LOS 
shorter and longer than 7 days was associated with shorter interval for subsequent COPD-
related readmissions. Considering the many negative effects of hospitalization on patients, our 
treatment goal should be prolonging the interval between hospitalizations. The results of a 
Canadian study based on a large COPD population clearly pointed out that patients were at 
highest risk of death within the first 7 days of hospitalization for acute exacerbation and thus 
special attention should be paid in this period.157 Therefore, LOS should be determined by the 
patients’ medical condition and not overcrowded hospitals, in spite of the health authority’s 
expectations of “treat more by less.”65 
 
5.2.2 COPD-related readmission 
After hospital discharge, many patients will be readmitted for COPD, and for some of them, 
in a relatively short time. History of hospitalization for COPD is the best single predictor of 
readmission.57 Furthermore, exacerbations tend to cluster in time and increase the risk of 
readmission in this period.158 According to Suissa et al., the risk of the next severe 
exacerbation requiring hospital admission peaks during the trimester after discharge, and the 
median time between successive severe exacerbation decreases with every new severe 
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exacerbation, from around 5.4 years from the first to second (given the patient not died) to 
less than 4 months from the 9th to the 10th.157 This is reflected in the high readmission rate, 
which is up to 60% in the subsequent year after the discharge.75,78 High readmission rates 
evoke concerns, and substantial efforts, mostly after hospital discharge, have been made to 
reduce them. The literature about interventions carried out while patients are still in hospital is 
sparse.  
 
In paper II, we compared COPD-related readmission rates during a 12-month follow-up 
period after an acute COPD exacerbation between patients discharged from a Pulmonary 
Department with comparable patients discharged from other medicine departments. Some of 
the patients discharged from the Pulmonary Department received a five-step program, 
including patient education addressing the recognition of symptoms of exacerbation and an 
action plan in case of new exacerbations. Unfortunately, their participation was not 
systematically registered and therefore the effect of this program could not be assessed. We 
found a non-significant trend of reduced readmission rate in favour of patients discharged 
from Pulmonary Department. This finding supports previous studies suggesting that COPD-
related readmissions are largely unrelated to the inpatient management process.73,83,84 
 
Studies have shown that other factors that can not be expected to be affected by a short 
hospital stay are important predictors of readmissions. These factors include history of 
hospitalization for COPD, quality of life, performance status or physical activity level, 
exposure to environmental tobacco smoking, age, sex and a low FEV1.73,75,83,159 Most of these 
factors reflect the severity of COPD and therefore are not amenable for short interventions 
such as hospital admission. In agreement with this, most interventions aiming to reduce 
readmission rates are performed after hospital discharge, e.g. in the community, including 
extensive patient self-management education, involvement of a multidisciplinary team and 
years of follow-up.117,118 This raises the question of whether it is realistic to reduce 
readmissions with interventions during the hospital stay.  
 
Probably, it is neither possible nor realistic to reduce the readmission rate for all patients 
admitted for COPD exacerbation. One randomised controlled trial (RCT) from Glasgow 
showed that a similar intervention as described earlier aiming at reduction of readmission rate 
had no effect considering the entire study population, but did affect a younger subpopulation 
not living alone. Evidence from other similar intervention studies also showed that only a 
limited subpopulation of hospitalized COPD patients met the inclusion criteria and all studies 
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experienced difficulties recruiting patients. For example, in the case of HaH, only 25% of 
screened patients fulfilled the inclusion criteria. In a study reported by Casas et al. that 
significantly reduced readmission rate, only 19% met the inclusion criteria. It may even be 
that the natural history of COPD, like the cluster phenomenon of exacerbation, increased 
frequency of severe exacerbations in advanced disease or simply aged patients, will prevent 
the reduction of readmission. It has been reported that only 4.7% of readmissions were 
preventable.160  Furthermore it might even be dangerous to prevent admissions if these are 
legitimate. Indeed, a RCT comparing the hospital readmission rate of patients with COPD 
who had usual care and a comprehensive management program combining education, an 
action plan for identification, treatment of exacerbations and scheduled telephone calls found 
that the intervention was associated with unanticipated excess of readmission rate and 
mortality.161 Therefore, it may be that not all readmissions are preventable and it has been 
claimed that “hospital readmission rate may not be the most important patient related outcome 
of health care” and whether an intervention should be implemented should not be only judged 
by its ability to reduce readmission rate.162 
 
5.2.3 Rethinking of traditional health care services 
5.2.3.1 Self-management  
The positive effect of self-management has been documented.79,80 It may even have economic 
benefits through reduced utilization of health care.163 Despite the promising effects, it remains 
unclear about what aspects of self-management programmes are most effective.164  
 
Our qualitative study showed that it is important that individualized, adapted information is 
delivered in a familiar environment (e.g. the patient’s home) by competent health 
professional. Our study showed that concrete and individualized information and advice may 
be easier to practice in the future. For example, one patient learned to distribute her energy 
more evenly and another patient learned to use an armchair in the living room to handle the 
dyspnoea attacks. We also believe that the environment where the information is delivered 
may influence which information is delivered. For example, the home environment reminded 
patients in our study about the challenges they met in everyday life and made it easier to 
remember discussing these challenges with the hospital nurse during the home visit. At the 
same time, the home environment offers an unique opportunity for health personnel to 
understand what patients struggled with and made it easier to make a personalized assessment 
of the concrete situations and offer solutions. To the contrary, the information that the 
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inpatients got was related mainly to the blood tests and other examinations performed in the 
hospital, and none of inpatients received other types of COPD-related information. It has been 
pointed out that one of the reasons the hospital failed to take care of people with chronic 
disease is the lack of information systems addressing prevention.165 
  
Furthermore, how and by whom the information is delivered may affect patients’ behavior. 
Home patients in our qualitative study valued the competence of the visiting nurse and the 
face-to-face contact they and their family caregivers got with the visiting nurse. Such face-to-
face contact gave a platform for the patient-centred care that has been shown to have a greater 
effect than other forms of traditional care such as outpatient clinics.166 Concrete, 
individualized information delivered in a familiar environment by competent health personnel 
may be important to mediating the knowledge of and facilitating behavior changes in patients.   
 
5.2.3.2 Patient’s experiences of good health care 
Continuity, interpersonal relationships and interaction between health care personnel are other 
premises of good quality care.167 The results from our qualitative study gave some examples 
of how important these factors were for the home patients. 
 
During the home treatment period of 3 days, the patients and their caregivers were visited by 
the same nurse, which gave them an opportunity to get to know each other. This continuity 
made a fundament for good interpersonal contact and dialog and mutual trust which made it 
easier for patients to ask questions. Through conversation and discussion, patients actively 
involved themselves in the treatment process. Their active involvement in deciding the next 
home visit time, which may be considered trivial, was one of the contributing factors of 
feeling safe and controlling the treatment process. Holman and Lorig, after studying arthritis 
patients, wrote more than 10 years ago that “involving patients in decision-making and 
treatment planning makes the delivery of care more effective and more efficient.”168 
  
To the contrary, none of the patients receiving hospital care in our qualitative study had the 
similar experiences of interaction or interpersonal relationship with the health care personnel. 
The lack of continuity of the staff might have prevented the establishment of interpersonal 
relationship and the patients’ active involvement in their own disease management. It seemed 
that the patients were used to a passive role created by the system, and they were satisfied and 
thankful for being “served.”  
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Availability was also important for patients who felt they had been taken care of. The home 
patients and their caregivers in our qualitative study appreciated the availability of the nurse 
during the home visit. In one hour, patients and their health problems were the main focus of 
conversation, especially issues about exacerbation and its prevention. Concrete suggestions 
were made without interruptions from other patients or routine works. In comparison, the 
patients receiving conventional hospital care, although staying at hospital 24 hours a day, did 
not expect the nurses “to sit down and talk a while.” They even showed a great understanding 
of this since the nurses had a lot of work to do and there were always other patients who 
needed help more. This form of fast-paced, fast talking health care is a result of the emphasis 
on expedience for service delivery, which directed nurses’ attention to the management of 
treatments and pulled them away from relating to patients in a caring way.169  
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6 Conclusion 
 
This study evaluated two outcomes related to hospitalization for acute exacerbation of COPD, 
the predictors of prolonged length of hospital stay and COPD-related readmission rate in 
patients discharged from pulmonary and non-pulmonary departments. The quantitative data 
collected from the patients’ medical records showed that the admission day of the week, co-
morbidities, PaCO2 and serum albumin level were associated with the LOS. However, we 
were unable to create a robust predicting model for LOS.  
 
The readmission rates between comparable patients with acute exacerbation of COPD 
discharged from the Pulmonary Department and other medicine departments for 12 months 
following an index hospitalization did not differ significantly. 
  
The qualitative data, collected through in-depth interviews with patients who participated a 
Hospital at Home treatment programme for acute exacerbation of COPD, showed that the 
patients experienced the home treatment programme as safe. The individualized, adapted 
information helped patients manage their disease afterward. What patients experienced as 
important aspects of treatment programme is important knowledge for developing new and 
effective health services.
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7 Implications 
 
The reasons for prolonged length of hospital stay for COPD exacerbation are probably 
multidimensional. Our findings, together with knowledge from other studies, suggest that 
non-patient factors such as organizational factors may be as important as patient factors in 
predicting length of stay, and more researches in this area are needed in the future.  
 
COPD-related readmission remains a challenge to the existing health care system. As Price et 
al. pointed out in the second UK National COPD Audit “none of the resource or 
organisational factors accounted for the variation in readmission rate.”83 Readmission rates 
are seen to be a ‘failure’ by the health service to address the multiple needs of COPD patients.  
This failure probably reflects the challenge of chronic disease to a system that was 
constructed to handle acute conditions. The challenge will remain and even become bigger if 
the health care system does not adapt to the paradigm change, e.g. the transition from 
communicable disease to chronic disease.165  
 
According to the World Health Organization’s report, “Innovative Care for Chronic 
Conditions,” chronic conditions will be responsible for approximately 60% of disease burden 
worldwide in 2020.165 The report pointed out several aspects of the existing organization of 
health care which does not fit the needs of chronically ill patients—failure to address 
prevention, absence of information system and failure to connect community resource. One 
Norwegian report also showed that increased fragmentation in the specialist health services 
creates problems for cooperation within specialist health services and between primary and 
specialist health services, and this can prevent offering good health care for patients with 
chronic diseases.170 The health care system, which is designed for the treatment of acute 
conditions and treats symptoms when they come, needs to be improved to meet the “multiple 
needs of COPD patients.”83 To enable COPD patients to take responsibility for daily 
management, behaviour changes and become the principal caregivers, the health care system 
needs to give patients knowledge and tools, offer competent support and offer good quality 
chronic care.171 
  
Patient safety deserves more attention from the health care system. Patients with chronic 
diseases have different needs that are not satisfactorily met by today’s health care system. The 
existing health care services should deliver chronic care of good quality and involve patients 
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in the management of the complex chronic condition. This may benefit both the patients and 
the health care system. 
 
Qualitative method may help us better understand the results gained from quantitative 
research and thus deserves more attention in medicine research. 
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9 Appendix  
 
INTERVJUGUIDE 1 
 
For hjemmebehandlede pasienter 
[Innledning - informasjon om intervjuet] 
x Informer om formålet med intervjuet og at det vil ta ca 1--1,5 time. 
x Spør om å få tillatelse til å ta opp samtalen på band (- lydbandopptak) for å kunne 
transkribere senere. 
 
TEMAER 
 
[1. Litt om sykehistorie og behandlingsapparat] 
x Hvor lenge har du hatt KOLS? 
x Har du deltatt i noen behandlingsprogram for KOLS tidligere? 
(slik som KOLS-skole, fysioterapi eller andre rehabiliteringsprogram) 
x Har du opplevd liknende episoder før - at du har vært så dårlig over flere dager at du 
har blitt lagt inn på sykehuset (pga KOLS), (Fortell litt om (en) tidligere 
sykehusinnleggelse...). 
 
[2. Behandlingsopplegget "sykehusbehandling i hjemmet"] 
x Kan du fortelle om sykehusinnleggelsen (nå sist) - og hjemmebehandlingen? 
1. Hvordan "så" dagene dine ut disse 3 dagene du fikk "sykehusbehandling i 
hjemmet"? (- fra morgen til kveld og natt mht pleie/stell, behandling, mat, røyking 
osv.) 
2. Fortelle litt om behandlingsopplegget (prøver som ble tatt, behandlinger og 
hjelp/veiledning) 
3. Var du i kontakt med andre på sykehuset i løpet av disse 3 dagene?  
(- Hvem kontaktet du, hvordan og hvorfor?) 
4. Fikk du hjelp av andre disse 3 dagene – eller klarte du deg selv etter de daglige 
hjemmebesøkene fra sykehuset? 
(Hva fikk du eventuelt hjelp til - og av hvem (pårørende/familie, 
venner/naboer, kommunal pleie- og omsorgstjeneste?) 
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[3. Behandlingsutbytte fra "sykehusbehandling i hjemmet"] 
x Hvordan har du det nå?  
x Er det noe fra behandlingsopplegget - "sykehusbehandling i hjemmet" - du kan 
bruke i dagliglivet etterpå? 
x Har behandlingsopplegget gitt deg noe – eller var det bare (nødvendig) hjelp der og 
da? (- mtp handtering av KOLS, medisinering, bruk av medisinsk utstyr/tekniske 
hjelpemidler, kosthold/ernæring, røykevaner/røykeslutt m.m) 
 
[4. Opplevelser av og begrensninger ved behandlingsopplegget] 
x Hvordan opplevde du det a fa sykehusbehandling i ditt eget hjem - fremfor på 
sykehus? (- positivt/negativt, fordeler/ulemper mtp behandlingsopplegg/-rammer) 
x Hvordan tror du dine nærmeste 
(ektefelle/samboer, pårørende/familie) opplevde det at du fikk 
"sykehusbehandling i hjemmet" – fremfor på sykehus? 
x Er det noe ved behandlingsopplegget "sykehusbehandling i hjemmet" som burde 
være annerledes, synes du? 
(Negative sider/ulemper – ved behandlingsopplegget/-rammene?) 
x Om du far tilbud om a fa hjemmebehandling en gang til, ville du ha valgt det 
igjen? Hvorfor? 
 
[5. Avslutning] 
x Jeg har fått svar på det jeg ønsket å snakke med deg om! 
1. Er det noe vi ikke har snakket om - i forhold til "sykehusbehandling i 
hjemmet"? 
2. Eller noe du vil tilføye tilslutt? 
x Tusen takk for all informasjon jeg har fått fra deg! 
1. Hvis det er noe du kommer på i ettertid, må du gjerne kontakte meg igjen. 
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INTERVJUGUIDE 2 
 
For sykehusbehandlede pasienter 
 
1. Kort innledning om formålet med intervju er at vi gjerne vil høre om pasientens 
opplevelse om sykehusinnleggelse under KOLS-forverring. 
 
x Hvordan så dagene ut de dagene du lå på sykehuset? 
 
x Hvordan synes du behandlingen har vært på sykehuset? 
 
x Tror du det ville ha sett annerledes ut hvis du var hjemme? 
 
x Svarer opplevelse forventningene du hadde før du ble innlagt? 
 
x Er det noe du savner ved sykehusoppholdet? 
 
x Hvordan opplevde dine pårørende sykehusoppholdet? 
 
x Har du fått noe igjen (noe info/kunnskap om KOLS) etter sykehusoppholdet? 
 
2. Hvorfor ville du delta prosjektet? 
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10. Errata 
1) Side 8, Abbreviation. 
From ”AECOPD  Acute exacerbation of chronic obstructive lung disease”  
To “AECOPD  Acute exacerbation of chronic obstructive pulmonary disease” 
 
2) Side 13, Section 1.2.1, paragraph 3, 2nd sentence.  
From “American Thoracic Society (ATS) and European Respiratory Society (ERS)” 
To “ATS and ERS”. 
 
3) Side 14, Section 1.2.2, paragraph 1, 4th and 5th sentence.  
From “Both long and short LOS is associated …  
To “Both long and short LOS had been associated …”.  
 
4) Side 14, Section 1.2.2, paragraph 2, 1st sentence.  
From “Different variables are associated with long LOS, such as social/demographic 
data, clinical variables, co-morbidities, number and type of drugs used and day of the 
week for admission are associated with long hospital stays in acute exacerbation of 
COPD” 
To “Different variables have been associated with long LOS in acute exacerbation of 
COPD, such as social/demographic data, clinical variables, co-morbidities, number 
and type of drugs used and day of the week for admission.”  
 
5) Side 14, section 1.2.2, paragraph 3, 4th sentence.  
From “Increased knowledge about predictors of length of stay (LOS) may …”  
To “Increased knowledge about predictors of length of stay may contribute…”  
 
6) S16, section 1.2.5, 2nd sentence.  
From “…treatment of prevention …” To “…treatment of exacerbation …”  
 
7) S16, section 1.2.5.1, 1st sentence.  
From “HaH has …” to “Hospital at home (HaH) has …”  
 
8)  Side 20, section 1.2.6, 1st paragraph, 3rd sentence.  
From “A survey showed more satisfaction in patients in the HaH programme than with 
patients receiving…”  
To “A survey showed more satisfaction in patients in the HaH programme than 
patients receiving…”  
 
9) Side 25, section 3.1.5, paragraph 2, 5th sentence.  
From “After matching process, we got to comparable patients…”  
To “After matching process, we got two comparable patients…”  
 
10) Side 27, section 3.2.4, paragraph 1, 2nd sentence.  
From “This methods….” to “This method….”.  
 
11) Side 36, section 5.1.3.2, paragraph 1, 2nd sentence.  
From “The interviews were audio-taped transcribed word by word right after the 
interview by me self.”  
To “The interviews were audio-taped and transcribed word by word right after the 
interview by myself.”  
 
I
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Abstract 
 
Background 
Reduction of the length of stay (LOS) in acute exacerbation of chronic obstructive pulmonary 
disease (AECOPD) requires the ability to identify patients who may require a long stay. This 
study assessed the association between variables obtained on hospital admission and long 
LOS, aiming to establish a prediction model for LOS.  
Methods 
We extracted demographic and clinical data from the medical records of 599 patients 
discharged after an AECOPD episode between March 2006 and December 2008 at Oslo 
University Hospital, Aker. We used univariate and multivariate logistic regression analyses to 
assess predictors of a LOS above the 75th percentile and assessed the area under the operating 
characteristic curve (AUC) to evaluate the model’s performance. 
Results 
We included 590 patients (54% women) aged 73.2r10.8 years (meanrSD) in the analyses.  
Median LOS was 6.0 days (IQR 3.5–11.0). In multivariate analysis, admission during 
Thursday–Saturday (OR 2.24 [95% CI 1.60–3.51], p<0.001), ≥1 comorbidity (OR 2.08 [95% 
CI 1.08–4.02], p=0.028), high PaCO2 (OR 1.26 [95% CI 1.13–1.41], p<0.001) and low 
albumin level (OR 0.92 [95% CI 0.87–0.97], p=0.001) were associated with a LOS of >11 
days. The statistical model had an AUC of 0.70. 
Conclusion 
Admission on Thursday–Saturday, comorbidities, high PaCO2 and low albumin level were 
associated with a long LOS. These findings may help physicians to identify patients that will 
need a long LOS in the early stages of admission. However, the predictive model exhibited 
suboptimal performance and hence is not ready for clinical use. 
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Introduction 
 
Hospitalization for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) 
is recognized as a major event in the natural history of chronic obstructive pulmonary disease 
(COPD) due to its negative effect on lung function, survival, risk of readmission and quality 
of life.1-6 Although only 10–15% of all patients with COPD will experience severe 
exacerbations that require hospital admission, the expenditure on hospitalization represents 
more than 70% of all COPD-related medical care costs.7 The mean length of stay (LOS) for 
patients hospitalized for AECOPD is long, reportedly ranging from 3 to 16 days.8,9  
Various variables like social/demographic data,10,11 clinical variables,9,12-14 
comorbidities,15-18 number and type of drugs used,19 and day of the week of the admission16 
are associated with long hospital stays in AECOPD. However, there is little consistency in the 
predictors of long LOS identified by different studies. To our knowledge, there are no 
established statistical models for predicting LOS based on variables collected at the time of 
hospital admission for AECOPD. Increased knowledge about predictors of the LOS might 
contribute to better discharge planning and shortening of the LOS. 
The primary objective of this retrospective study was to identify factors associated 
with a long LOS—defined as longer than the 75th percentile—in patients hospitalized for 
AECOPD. A secondary objective was to develop a predictive model for LOS based on 
available variables obtained at the time of admission for AECOPD. 
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Material and methods 
Patients 
The study included all patients with a discharge diagnosis of COPD between March 2006 and 
December 2008 at Oslo University Hospital, Aker. We included patients with COPD (J43 or 
J44) based on the International Statistical Classification of Disease and Related Health 
Problems, 10th Revision (ICD-10)20 as the main diagnosis, or respiratory failure (J96) or 
pneumonia (J12–J18) as the main diagnosis with COPD (J43 or J44) as a secondary 
diagnosis. We only included the first hospitalization for patients with multiple hospitalizations 
during this period. In total, 599 patients were included.  
 
Medical record review and variables 
We extracted the following data from the computerized medical record at the time of hospital 
admission: demographic data, number of comorbidities, use of long-term oxygen therapy and 
clinical data obtained in the emergency department (Table 1). As comorbidities, we registered 
a history of any of the following conditions: ischemic heart disease, cardiac arrhythmias, 
congestive heart failure, cor pulmonale or pulmonary hypertension, psychiatric disorder, 
general atherosclerosis, cerebral insult, diabetes mellitus, other neurologic disorders than 
cerebral insult, any malignancy ever, osteoporosis, kidney failure, or abuse of drugs or 
alcohol. 
We also extracted the value of the forced expiratory volume in 1 s (FEV1) determined 
at the time closest to that of the admission, LOS, number of COPD-related admissions during 
the previous 12 months before the current admission and the day of the week of the 
admission. In the analyses we dichotomized day of the week into Thursday–Saturday and 
Sunday–Wednesday, because we considered that the natural time of discharge for those 
admitted during Thursday–Saturday would be before the following weekend and thus that 
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they might have a higher risk of a prolonged stay. A COPD-related admission was defined by 
discharge diagnoses from previous admissions using the same criteria as for the current 
admission. 
This study was approved by the local Privacy Ombudsman for Clinical Research, Oslo 
University Hospital.  
 
Statistical analysis 
Based on a literature review we analysed how 14 variables from our data set were related to 
LOS (Table 1). Descriptive statistics are expressed as meanrSD or median [interquartile 
range (IQR)] values for continuous data, and number (%) values for categorical data. Missing 
values for FEV1, serum albumin level and the partial carbon dioxide tension in arterial blood 
(PaCO2) were imputed from the other known variables using multiple linear regression 
analysis; we did not impute missing values for the other variables. Patients with missing 
values after this procedure were excluded from the final analysis. We used univariate and 
multivariate logistic regression analyses to assess predictors of a LOS of >11 days 
(corresponding to >75th percentile). The multivariable analysis initially included variables 
with p≤0.25 in the univariate analysis. We then manually removed variables one by one while 
watching changes in the coefficients in order to arrive at a final parsimonious model. We 
chose a significance level of 5%. Stata software (version 10.1) was used for statistical analysis 
(Stata Corp, College Station, TX, USA). 
In an attempt to establish a statistical model to predict whether or not a patient would 
be hospitalized for longer than the 75th percentile, receiver operating characteristic (ROC) 
analysis was performed for independent predictors of a long LOS as determined by 
multivariate logistic regression analysis.  
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Results 
Study subjects 
Of 599 patients discharged after AECOPD, 9 were excluded from further analysis due to 
missing data after our imputation of FEV1, serum albumin and PaCO2 values. The final 
sample of 590 patients had a mean age of 73.2r10.8 years and comprised 54% females. The 
mean LOS was 8.9r9.7 days, with a median of 6 days (IQR 3.5–11.0 days). Descriptive 
statistics for the patients are presented in Table 1.  
In univariate analysis, FEV1, COPD-related admission during the previous 12 months 
before the current admission, admission during Thursday–Saturday, having at least one 
comorbidity, high PaCO2 and low serum albumin level were significantly associated with a 
LOS longer than 11 days (p<0.05, Table 2).  
In multivariate analysis, only admission during Thursday–Saturday, having 
comorbidity, high PaCO2 and low serum albumin level were independently associated with a 
long LOS (Table 3). Admission during Thursday–Saturday increased the odds ratio (OR) of a 
LOS longer than 11 days to 2.24 [95% confidence interval (CI) 1.60–3.51]. The OR for the 
presence of comorbidity compared with no comorbidity was 2.08 (95% CI 1.08–4.02). An 
increase of 1 kPa in PaCO2 had an OR of 1.26 (95% CI 1.13–1.41), and an increasing serum 
albumin level was associated with a shorter LOS (OR 0.92 [95% CI 0.87–0.97]). The area 
under the ROC curve was 0.70 (Figure 1).  
 
Discussion 
This study found that admission from Thursday through Saturday, comorbidities, high PaCO2 
and low serum albumin level were independently associated with a long LOS. However, the 
statistical model had an area under the ROC curve of 0.70, which we considered to be too low 
to allow the development of a meaningful predictive model.  
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 Our finding that admission during Thursday–Saturday was associated with a LOS 
greater than the75th percentile (i.e., 11 days) is consistent with a Spanish study demonstrating 
an association between weekend admission (Friday–Sunday) and prolonged LOS.16 However, 
a long LOS was defined as ≥3 days in the Spanish study, which is shorter than the median in 
the present study, and shorter than the commonly reported mean or median LOS of 6–11 
days.21 Studies of other diseases have also found that the admission day of the week affects 
the LOS.22,23 There are several possible explanations of this phenomenon, and they probably 
vary between specific health systems. In our case it might be that the “natural” discharge day 
of these patients was immediately before the next weekend, as indicated by the median LOS, 
and hence the discharge could be delayed by the discontinuity and reduction of the medical 
staff during weekends, as suggested by previous studies.16,22 This phenomenon might also be 
due to the reduced primary health care or support available from relatives following the 
hospital discharge.  
The association between LOS and comorbidity—which is common in COPD—was 
less surprising, and supports the findings of previous studies.15-18  
That a high PaCO2 measured in the emergency department was associated with a 
prolonged LOS is reasonable because PaCO2 and other blood-gas variables reflect the severity 
of respiratory failure. This finding is consistent with two previous studies12,24 but inconsistent 
with two others.25,26 The discrepant results of these studies may be due to differences between 
the patient populations, since patients needing intensive care26 and with infiltration on chest 
radiographs25 were excluded from the latter two studies. 
Our finding of an association of low serum albumin with a long LOS is consistent with 
a British study demonstrating an association between a low serum albumin level and a LOS of 
>7 days.24 The serum albumin level is a marker of nutritional status,27 with a low level being 
associated with higher long-term mortality in COPD patients.2,28 Albumin also forms a part of 
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the acute-phase protein response, and hence low serum albumin may reflect the deterioration 
of clinical status or increased persistent inflammation during AECOPD.28  
In the present study we wanted to identity patients with anticipated long LOS 
primarily because such patients may have a worse health status and hence an increased need 
for post-discharge support.29 We decide to use a LOS cutoff of the 75th percentile rather than 
the median based on the assumption that the potential benefit from improved discharge 
planning would be greater for the former.  
The predictive model did not perform was well as we had anticipated. The area under 
the ROC curve was only 0.7, suggesting a poor to fair performance. One example of why we 
are not satisfied with the predictability of the model is that if we wanted it to identify 90% of 
all patients with a LOS of >11 days (i.e. a sensitivity of 0.90), then according to the ROC 
curve the specificity would be 0.33; that is, in 67% of cases the model would have picked up 
patients with a LOS of ≤11 days. Such a high false-positive rate would make the predictive 
model of little use in clinical practice. There may be several reasons for the suboptimal 
performance of this model, with one possibility being the presence of a large random 
component that is independent of patient-related variables. Previous studies found that only 
8–12% of the LOS variation could be explained by clinical variables;14,25 local practice 
guidelines, hospital resources and the organization of care could be such independent 
components.24,30  
Some limitations of this retrospective study should be discussed. Firstly, the number 
of variables used in the analyses was limited, meaning that potentially important predictors 
might have been missed. However, we reduced the possibility of false-positive findings by 
including large numbers of variables in the analysis. Secondly, some medical records at the 
time of the admission were incomplete, for example, lacked information on comorbidities or 
results of test actually being done on admission. This was partially compensated by imputing 
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values for missing values for variables that we though would be most important: FEV1, 
PaCO2 and albumin. This imputation contributed to reduce the uncertainty associated with 
missing data and avoid the exclusion of patients, which would have reduced the statistical 
power of the study.  
Lastly, the study population was recruited from a single university hospital in Oslo, 
and it might not be representative of other regions. However, the included population was 
relatively large and was unselected in that all patients with a discharge diagnosis of COPD 
were included. Furthermore, both age and LOS in our study were comparable to those in 
previous larger studies,24,31 which support the representativity of our sample. 
In conclusion, we found that the admission day of the week, comorbidities, PaCO2 and 
serum albumin level were associated with the LOS. The reported findings may help 
physicians to identify patients at risk of a long LOS in the early stages of an AECOPD 
admission. However, we were unable to create a robust scoring model for risk stratification 
that would have been useful for discharge planning. The reasons for prolonged LOS are 
probably multidimensional, and future studies should focus on both patient- and non-patient-
related factors.  
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Table 1. Descriptive statistics for patients hospitalized for COPD and included in the final 
analysis (n=590), meanrSD or number (%). 
 
Variables Values 
Age, years                                                  73.2r10.7 
Sex, female                                                     319 (54) 
Mean arterial blood pressure, mmHg              104r16.4 
Pulse rate, beats/min                                          95r21.7 
PaCO2, kPa                                                      5.9r1.6 
Serum albumin level, g/l                                  38.8r4.6 
FEV1, l/s  1.0 r0.50 
Patients living in an institution                          61 (10) 
Long-term oxygen therapy                                42 (7) 
X-ray findings consistent with pneumonia       176 (30) 
At least one comorbidity                                   498 (84) 
Psychiatric diagnosis                                        87 (15) 
At least one COPD-related admission*           111 (19) 
Admission Thursday–Saturday            237 (40) 
PaCO2, partial pressure of carbon dioxide in arterial blood; FEV1, forced expiratory volume in 
1 s; COPD, chronic obstructive pulmonary disease.* At least one COPD-related admission                             
within 12 months prior to index admission      
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Table 2. Results of univariate logistic regression analysis of a length of stay (LOS) of >11 
days vs ≤11 days during admission for acute exacerbation of COPD (n= 590). 
Risk factor Odds ratio 95% CI p 
Age, years 
Sex, female vs male 
Pulse, beats/min  
Long-term oxygen therapy   
Mean arterial blood pressure, mmHg 
X-ray findings consistent with pneumonia 
Psychiatric diagnosis 
Patients living in an institution 
FEV1, l/s 
At least one COPD-related admission*  
1.03 
0.97 
1.01 
1.21 
0.99 
1.23 
0.94 
1.28 
0.64 
1.66 
1.01 – 1.04 
0.66 – 1.40 
1.00 – 1.01 
0.60 – 2.43 
0.98 – 1.00 
0.82 – 1.83 
0.55 – 1.60 
0.72 – 2.31 
0.42 – 0.97 
1.06 – 2.59 
0.005 
0.852 
0.185 
0.589 
0.164 
0.314 
0.825 
0.401 
0.034 
0.027 
Admission Thursday–Saturday      2.22 1.52 – 3.23 <0.001 
PaCO2 (kPa) 1.25 1.12 – 1.40 <0.001 
Serum albumin level, g/l 0.93 0.89 – 0.97 0.001 
Comorbidities, ≥1 vs 0 2.50 1.32 – 4.74 0.005 
CI, confidence interval. * At least one COPD-related admission within 12 months prior to 
index admission     
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Table 3. Results of multivariate logistic regression analysis of a LOS of >11 days vs ≤11 days 
during admission for AECOPD (n= 590). 
Risk factor Odds ratio 95% CI p 
Admission Thursday–Saturday             2.24 1.60 – 3.51 <0.001 
PaCO2, kPa 1.26 1.13 – 1.42 <0.001 
Serum albumin level, g/l 0.92 0.89 – 0.97 0.001 
Comorbidities, ≥1 vs 0 2.08 1.08 – 4.02 0.029 
CI, confidence interval. 
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Figure legend 
 
Figure 1. Receiver operating characteristics curve for the multivariate logistic regression 
model. 
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Patients with acute exacerbation of chronic
obstructive pulmonary disease feel safe when
treated at home: a qualitative study
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Abstract
Background: The design of new interventions to improve health care for patients with chronic obstructive
pulmonary disease (COPD) requires knowledge about what patients with an acute exacerbation experience as
important and useful. The objective of the study was to explore patients’ experiences of an early discharge hospital
at home (HaH) treatment programme for exacerbations in COPD.
Methods: Six exacerbated COPD patients that were randomised to receiving HaH care and three patients
randomised to receiving traditional hospital care were interviewed in semi-structured in-depth interviews. Four
spouses were present during the respective patients’ interviews. The interviews were audio-taped, transcribed and
analysed by a four-step method for systematic text condensing.
Results: Despite limited assistance from the health care service, the patients and their spouses experienced the
HaH treatment as safe. They expressed that information that was adapted to specific situations in their daily lives
and given in a familiar environment had positive impact on their self-management of COPD.
Conclusion: The results contribute to increased knowledge and awareness about what the patients experienced as
important aspects of a HaH treatment programme. How adapted input from health services can make patients with
exacerbation of COPD feel safe and better able to manage their disease, is important knowledge for developing
new and effective health services for patients with chronic disease.
Keywords: Hospital at home treatment, Acute exacerbation of COPD, Qualitative interviews, Patient perspective
Background
Chronic obstructive pulmonary disease (COPD) has be-
come a major cause of morbidity and mortality during
the last two decades and is expected to become the third
leading cause of death worldwide in 2030 [1]. Acute ex-
acerbation of COPD resulting in hospitalisation is a ser-
ious event for patients, and frequent hospitalisations
have been related to reduced survival [2] and impaired
quality of life [3]. Demographic changes with an increas-
ing number of older people with chronic diseases with
the demand for acute care hospital beds can be expected
to increase. One way of organising help for some of
these patients is to provide hospital at home (HaH)
treatment [4].
Different HaH programmes for treatment of acute ex-
acerbation of COPD have been carried out and studied
in both randomised controlled studies [5-13], non-
randomised studies [14-19] and studies with retrospect-
ive analysis [20,21] in countries like the United Kingdom
[6,7,12-17], Spain [8,9,19], Australia [10] and Italy [5].
These studies have shown that it is feasible for selected
patients with acute exacerbation of COPD to be treated
at home, and that the participating patients were satis-
fied [12,13]. Some studies have found significant cost
savings with HaH [9,10,22], but other studies have not
been able to confirm this [5,23].
A systematic review from the Norwegian Knowledge
Centre for the Health Services concluded that patients
with acute exacerbations of COPD, who were rando-
mised to HaH treatment, had a lower readmission rate
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than patients who were randomised to conventional in-
patient hospital treatment [22]. Treatment at home
showed a statistically non-significant trend towards lower
mortality. Finally, the review concluded that it is uncer-
tain whether patients and next of kin are satisfied with
receiving HaH treatment [22].
Some qualitative studies have been carried out on
patients’ experiences of HaH programmes. Clark et al.
concluded that not all patients found the home nursing
component of the services helpful, and that the patients
felt that they were not being actively involved in the
early discharge process [23]. Schofield et al. on the other
hand found that the majority of the patients and their
family preferred home care service rather than hospital
care [24]. A qualitative study on experiences of patients
with COPD who had participated in an extensive self-
management treatment intervention including self-
management education course and a fitness programme
in an outpatient clinic, found that the patients felt safe
[25]. However, a detailed description of the patients’
experiences of the home treatment programme is lacking
[24,25].
The objective of the present study was to explore
COPD patients’ experiences of a limited early discharge
HaH treatment programme. We concentrated on aspects
of special importance to the patients during and after
the acute treatment period. Knowledge about what
patients experience as helpful health care services and
support is needed in development of new ways of orga-
nising and carrying out patient treatment.
Methods
Subjects
Patients were recruited from consecutive participants in
a randomised controlled trial (RCT), investigating long-
term effects of a HaH programme. The main inclusion
criteria of the RCT were that the patients were consid-
ered to have acute exacerbation of COPD according to
the definition adopted by the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) [26,27] and
needed hospital admission. The main exclusion criteria
were life threatening respiratory failure, confusion,
impaired consciousness and changes in chest x-ray or
comorbidities in need of further inpatient investigation
or treatment. Within 36 hours the patients were allo-
cated to HaH or continued hospital treatment. This
RCT experienced a slow inclusion rate and was termi-
nated after a year because of this. At this point 12
patients were included.
The 12 patients included in the RCT were considered
eligible for inclusion in this qualitative study. After ex-
cluding three patients because their medical condition
had worsened, all of whom had received in-hospital
treatment, nine patients were included (Table 1). Six
patients received HaH treatment (HaH patients) and
three received traditional hospital treatment (inpatients).
The inpatients were interviewed in order to see the HaH
patients’ experiences in light of traditional hospital care.
Written informed consent was obtained from the parti-
cipants, and the study was approved by the Regional
Committee for Medical Research Ethics (REK), South-
East Norway.
The hospital at home treatment programme
A specialised hospital nurse visited the HaH patients up
to one hour daily over a period of three days after
hospital discharge. The nurse evaluated the patients’
clinical status, essential clinical parameters, obtained
blood samples for later analysis when needed, and
assessed whether or not the patients could still be trea-
ted at home. The nurse could consult a pulmonologist
in case of worsening of the patients’ symptoms. After
the consultation, decisions were made on frequency of
follow-up, therapy changes or readmission to the hos-
pital. Furthermore, the nurse invited the patient and his/
her spouse to a dialogue, e.g. she asked how the patient
felt and encouraged them to reflect on possible causes of
the acute exacerbation and how to prevent it. During
the three-day period the patients were allowed to call
the hospital at any time if they were concerned about
their condition, especially regarding indications for
readmission. Inpatients were treated according to ordin-
ary hospital routines.
Both patient groups were during the subsequent year
offered three outpatient follow-up consultations with a
pulmonologist in the hospital. The first visit was ap-
proximately six weeks after discharge.
Data collection and analysis
The empirical data were obtained from semi-structured,
audio-taped in-depth interviews based on Kvale’s princi-
ples [28]. The researcher had prepared interview guides
for the two informant groups (HaH patients and inpati-
ents) before the interview, but the guides were used
flexibly. This implied that all the questions in the guide
were asked, but different topics could be explored more
deeply in different interviews, and that new topics could
be brought up by the informants during the interviews.
The interviews included questions about the patients’
experiences and their benefit of the treatment programme.
The interviews were carried out in the patients’ home
between seven and ten weeks after hospital discharge, ex-
cept for one interview that was conducted in the out-
patient clinic. The interviews lasted between 60 and
90 minutes with the HaH patients, and 30 minutes with
the inpatients. Four spouses (three of the HaH patients
and one of the inpatients) were present and participated
in varying degree. The first author, a medical doctor,
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carried out and transcribed the interviews. She was
trained in asking open-ended rather than closed questions
and in asking the participants about not only positive, but
also negative experiences with the HaH programme [28].
The analysis was carried out in collaboration with the
supervisors.
Interview transcripts constitute our data material. It
was analysed according to a systematic text condensing
method in the following four steps alternating between
the various steps throughout the entire process as
described by Malterud [29]: 1) Reading through the
whole material to obtain an overall impression; 2) Iden-
tifying themes representing different aspects of the
patients’ experiences and coding these under different
thematic headings (i.e. coding groups). The coding
groups “feeling safe,” “individually adapted information,”
and “managing strategies” were developed; 3) Abstract-
ing and condensing the content within each coding
group; and 4) Summarising the content within each
thematic heading. Suitable citations were chosen to
illustrate the findings.
The analysis focused on the patients’ experiences of
the HaH programme, and whether the patients had
obtained something from the programme that helped
them to manage their chronic illness in everyday life.
This was seen in light of the inpatients’ experiences of
traditional hospital care.
Results
Feeling safe
The patients spontaneously described the HaH
programme as safe, mainly according to the daily visits
of the nurse. The patients emphasised different aspects
of the programme that contributed to their experiences
of feeling safe, e.g. the treatment predictability due to
the cooperation with the nurse when deciding the time
of the visits. Daily examinations of clinical parameters
were experienced as “very reassuring.” One summed it
up as the following:
“It was safe, because I knew she was coming! If I did
not feel 100% well, I knew that she was coming
tomorrow to check me.” (HaH patient 5)
The patients also pointed out the importance of the
possibility of telephone consultation with the pulmonary
department and instant readmission when needed.
Several patients drew attention to how reassuring it
was to have time for asking questions and talking with
the nurse during the visits. One HaH patient said:
“The more you know, the safer you feel. You are not
so frightened when you know what is what and get a
proper explanation of this [disease].” (HaH patient 1)
Four patients appreciated that the nurse would ask,
“How are you?” They remarked that she was interested
Table 1 Characteristics
Hospital at home treatment programme Hospital care
On admission
Sex Female Female Female Male Male Male Female Female Male
Age (yrs) 51 71 71 70 71 79 54 77 77
Marital status Married Widow Widow Married Married Married Divorced Widow Married
Comorbidities Anxiety
Depression
Heart Disease
Hypertension
Heart Disease
Hypertension
Hypertension Diabetes
mellitus
Hypertension
Diabetes
mellitus
Hypertension
Anxiety Diabetes
mellitus
Inflammatory
bowel disease
Heart
disease
GOLD stage II I III III III II III III III
Blood pressure
(mmHg)
150/80 180/80 140/75 155/90 150/90 140/70 140/75 150/80 97/53
Pulse rate min-1 108 56 87 75 88 61 105 110 60
PaO2 (kPa) 8.27 8.45 10.9 7.57 11.4 8.93 9.18 8.74 8.13
Respiratory rate min-1 24 22 20 35 24 18 17 20 25
Number of drugs 5 8 8 5 8 10 5 8 8
At 6 weeks control
FEV1 (l/s) (% of
predicted)
1.68 (59%) 1.89 (97%) 0.5 (31%) 1.4 (37%) 1.3 (40%) 2.1 (75%) 0.9 (39%) 0.8 (41%) 1.3 (42%)
MRC dyspnoea scale 5 3 3 2 2 2 3 4 2
BMI (kg/m2) 41 33 24 38 33 30 30 26 24
6-minute walk test (m) * 508 272 500 125 510 280 350 500
IBD: Inflammatory bowel disease; GOLD: Global Initiative for Chronic Obstructive Lunge Disease; PaO2: arterial oxygen tension; FEV1: forced expiratory volume in
one second; MRC: Medical Research Council dyspnoea scale, range (1–5); BMI: Body mass index; *not carried out due to a knee injury.
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in listening to how they felt. Some also mentioned the
comprehensible way the nurse had explained things and
her high competence that made them feel like they were
“in safe hands.” The patients used words such as “very
pleasant,” “cosy” and “a caring person” to describe the
visiting nurse.
Two patients, both readmitted, said that they retro-
spectively felt that the discharge from the hospital within
36 hours after admission might be too early. However,
both patients would choose home treatment again. A
third patient wished for a longer home treatment period
and perhaps also more than one visit a day.
Four patients emphasised the significance of being fol-
lowed up with three controls at the hospital during the
subsequent year. This contributed to their experience of
the programme as reassuring.
The three inpatients said they were very satisfied with
the hospital treatment. They were surprised by being
asked whether they felt safe during their hospital stay.
They expressed that they automatically felt safe after ad-
mitted to the hospital. Two of them said that they im-
mediately felt safe when hospitalised, although their
breath is still heavy. The statement of one of the
patient’s wife summed up the three inpatients’ experi-
ences as follows:
“I think one feels safe when doctors and nurses are
present: I believe it’s quite natural!” (Inpatient 3,
spouse)
Individually adapted information
The HaH patients emphasised information as important.
They valued “getting an explanation” and an understand-
ing of the disease and its consequences. This made them
feel safe and calm, as well as less anxious. Four patients
and two spouses remarked that the information was
detailed and related to concrete situations in their every-
day life. One patient stated that being treated at home
made it easier to concentrate on her challenges in daily
life:
“When you are at home you know what’s what, and
may think of various things that are relevant just then.
It was just me and her and nothing to disturb us.”
(HaH patient 1)
One patient’s wife appreciated that the nurse had
answered several questions concerning her worries for
her ill husband, e.g. questions related to breathing, diet
and lifestyle. One patient said the nurse had explained
many things in a comprehensible way, things she had
struggled with without being aware of it:
“She said that I do not need to get everything done in
one day even if I am in a good period. I learned to
distribute the energy evenly and listen to my body
signals. She made suggestions and put me on the
track to many good ideas.” (HaH patient 1)
The nurse had given advice related to how to manage
the limitations caused by COPD, be aware of symptoms,
e.g. cough, mucus and breathlessness and how to man-
age them. One patient had been advised to take it easy
at the start of physical exertion so that his “breath”
would last longer. She also gave advice on dealing with
the unpleasant influence of cold air in the winter. Four
patients mentioned that the nurse had discussed medica-
tion and how to use various medical equipments.
Two patients experienced the nurse’s information as
less helpful. One said she already had received similar
information at a previous rehabilitation programme. An-
other patient emphasised that the written information
he had received from the nurse was not fitting for his
specific case:
“There is something about smoking on every page [of
the brochure], but I have never smoked!” (HaH
patient 3)
According to the three inpatients, the information they
got during the hospitalisation was related to treatment
and results from various medical examinations. The
inpatients noticed that the hospital staff was busy, and
they did not expect them to have “time for sitting down
talking for half an hour,” as one said. They were sur-
prised when being asked whether there was some infor-
mation they missed. The following quotation summed
up their reactions:
“Is it possible to get any more information?”
(Inpatient 2)
Managing strategies
Three of the HaH patients described different aspects of
changes in their everyday life related to the received in-
formation, explanations and advice about management
of the disease from the visiting nurse. One patient
shared how he applied the advices: he had learned to re-
lieve the breathlessness during an acute attack by hang-
ing over the armchair in his living room. Earlier he used
to swallow the mucus, but he had begun to cough it up
even at night now. In order to breathe easier during the
night, he had elevated the head end of his bed.
Two patients said they had improved their routines
after receiving the HaH. One used to skip prophylactic
medication because she did not immediately experience
any effect. After she had been given an explanation of
how the medication works, she had begun to take it
regularly. Another patient used to take a cough mixture
before she went to bed to avoid coughing at night. She
stopped taking this drug after having been informed
about the negative effects of it. She also felt herself in a
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better physical and psychological mood after she began
to distribute her energy more evenly than before.
The three inpatients did not mention similar experi-
ences from having received information and advice dur-
ing the hospitalisation. They rather emphasised that they
were satisfied with the stay due to the quality of the ser-
vice from “the nice staff.” One said:
“[The staff] was constantly dropping in to ask if I was
thirsty or something. . .” (Inpatient 2)
One inpatient’s spouse remarked that she got the im-
pression that the hospital was mostly concentrated on
getting patients out.
Discussion
One main result of this study is that the HaH patients’
feeling of safety was their main experience from the
treatment programme and that this was crucial for their
positive experience of the programme. This was surpris-
ing considering the limited time of professional treat-
ment. The HaH patients felt they were being taken care
of due to the daily visits by the nurse, which seems to
contrast the results in another qualitative study [23].
Our analysis clearly indicated that the patients’ involve-
ment in deciding the schedule contributed to their feel-
ing of predictability of the treatment programme. That
the possibility to call the hospital at any time was highly
valued by the patients and probably functioned as a se-
curity net, is supported by the results in a qualitative
study by Monninkhof et al. [25].
To our knowledge, the importance of feeling safe has
previously not been demonstrated in studies on HaH
programmes with similar design with relatively limited
help as is the case in our study. However, participants in
a qualitative study on a considerably more comprehen-
sive programme lasting up to two years expressed that
they felt safe [25]. Moreover, two RCTs and one mixed-
method study found that the patients were satisfied with
and preferred HaH, but it is not in detail described why
and what made the participants in their study prefer
HaH [12,13,24].
An important finding in our study was that the HaH
patients appreciated the individually adapted informa-
tion they got, including those patients, who previously
had undergone a four weeks in-hospital rehabilitation.
The treatment programme took place and the infor-
mation was given in the patients’ home and this made it
easier for them to participate in the treatment process,
in contrast to passively waiting to be helped, as the inpa-
tients experienced. The home environment provided a
unique framework for the treatment and the informa-
tion. The patients were reminded about what they used
to struggle with in their everyday life and the nurse
could adjust her answers, information and advice to the
concrete situations and objects in the patients’ home
and teach them how to manage their disease. The infor-
mation was therefore related to the patients’ needs and
easy to remember and practice afterwards.
Another important aspect of the HaH was that the
nurse had enough time to talk with one patient at a time
without distraction, which routines in the hospital rarely
allow. This made it possible for the nurse to practise her
role as an adviser, treatment manager and teacher. It is
likely that self-management education is beneficial
for patients with COPD in a way that the patients
apply the knowledge from the education to guide self-
management over time [30]. Our findings show that the
patients appreciated the calm way the nurse worked,
without signalling being in a hurry, as also previously
reported to be valued in another study [24]. In contrast,
the inpatients’ stories reflect how modern care services
can be negatively interpreted. The health professionals
were perceived to be nice and trying to do a good job,
but their work was understood to be distracted by strict
routines and technological procedures. The inpatients
experienced that the staff was always in a hurry and
seemed to have little time for communicating with the
patients, but nevertheless appeared to do their best.
During the last five decades chronic diseases are major
causes of disabilities, and the aim of the treatment of a
chronic disease is to improve health related quality of
life and maintain independency for the patients [30]. In
the case of COPD, self-management is an important part
of living with this disease [31]. To teach patients skills
needed to carry out medical regimens and help them
manage their illness in everyday life are essential parts of
the treatment. Our findings indicated that the individua-
lised information and instructions from the nurse, given
in the patients’ homes and in connection to their every-
day life situations contributed to the patients’ experi-
ences of having control and feeling safe.
We chose the qualitative in-depth interview as a
method to develop knowledge of the patients’ experi-
ences of the HaH. Six HaH patients, selected through
the inclusion criteria to the RCT, may seem to be a small
number, but is not unusual few informants in a qualita-
tive study [29,32,33]. Although we did not manage to in-
clude more than six patients, we had god diversity in
our materials as regards age, gender, marital status and
GOLD-stage among our subjects (Table 1). In this
selected group of patients with COPD, we discovered
broadness in the patients’ experiences, which we
found comparable to studies with higher numbers of
patients [24,25].
Additionally, we consider the research method well
suited in the sense that we got rich information and new
knowledge despite that some patients had difficulties in
remembering detailed information. Interviews earlier
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than seven to ten weeks after the treatment may have
reduced the recall problems in some degree. We believe
the involvement of the spouses in the interviews was a
valuable informational supplement and interviews with
the inpatients shed light on the specific aspects of the
HaH.
Conclusion
The patients in this study experienced the HaH
programme as safe despite the limited help they
received. They expressed that information that was
adapted to specific situations in their daily lives and
given in a familiar environment had positive impact on
their self-management.
How adapted input from health services can make
patients with exacerbation of COPD better able to man-
age their disease, is important knowledge for developing
new and effective health services for patients with
chronic disease.
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